FORM 8-K |
COLONY CAPITAL, INC. (Exact Name of Registrant as Specified in Its Charter) |
Maryland | 001-37980 | 46-4591526 | ||
(State or Other Jurisdiction of Incorporation or Organization) | (Commission File Number) | (I.R.S. Employer Identification No.) |
515 S. Flower Street, 44th Floor Los Angeles, California | 90071 | |||||
(Address of principal executive offices) | (Zip Code) |
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). | |
Emerging growth company ¨ | |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨ |
Securities registered pursuant to Section 12(b) of the Act: | ||||
Title of Class | Trading Symbol(s) | Name of Each Exchange on Which Registered | ||
Class A Common Stock, $0.01 par value | CLNY | New York Stock Exchange | ||
Preferred Stock, 8.25% Series B Cumulative Redeemable, $0.01 par value | CLNY.PRB | New York Stock Exchange | ||
Preferred Stock, 8.75% Series E Cumulative Redeemable, $0.01 par value | CLNY.PRE | New York Stock Exchange | ||
Preferred Stock, 7.50% Series G Cumulative Redeemable, $0.01 par value | CLNY.PRG | New York Stock Exchange | ||
Preferred Stock, 7.125% Series H Cumulative Redeemable, $0.01 par value | CLNY.PRH | New York Stock Exchange | ||
Preferred Stock, 7.15% Series I Cumulative Redeemable, $0.01 par value | CLNY.PRI | New York Stock Exchange | ||
Preferred Stock, 7.125% Series J Cumulative Redeemable, $0.01 par value | CLNY.PRJ | New York Stock Exchange |
Date: | May 10, 2019 | COLONY CAPITAL, INC. | |
By: | /s/ Mark M. Hedstrom | ||
Mark M. Hedstrom | |||
Chief Financial Officer, Chief Operating Officer and Treasurer |
• | First quarter 2019 net loss attributable to common stockholders of $(102.1) million, or $(0.21) per share, and Core FFO of $47.7 million, or $0.09 per share |
• | Core FFO of $75.4 million, or $0.15 per share, excluding net investment losses of $27.7 million, which were composed of $14.1 million of losses on sale of and provision for loan losses on certain Other Equity & Debt investments and $13.6 million for our share of certain investment losses realized by Colony Credit Real Estate, Inc. (NYSE: CLNC) |
• | The Company’s Board of Directors declared and paid a first quarter 2019 dividend of $0.11 per share to holders of Class A and B common stock |
• | The Company closed on commitments of $310 million in third-party capital (including amounts related to affiliates) |
• | The Company completed the planned sale and/or monetization of $190 million of assets within the Other Equity and Debt segment resulting in net equity proceeds of $93 million |
• | The Company refinanced three near-term maturing loans with an aggregate consolidated balance of $266 million, or CLNY OP share of $222 million, in its Healthcare and Hospitality Real Estate segments extending term to 2024 at slightly more favorable interest rates on average |
• | The Company, through its Industrial platform, closed on the acquisition of a $1.2 billion value-add portfolio of 54 light and bulk industrial buildings located across 10 U.S. markets totaling approximately 11.9 million square feet |
• | Subsequent to the first quarter 2019: |
• | The Company completed its acquisition of Abraaj Group’s private equity platform in Latin America, which has been renamed Colony Latam Partners |
• | Digital Colony entered into a definitive agreement to acquire Zayo Group Holdings, Inc., which provides mission critical bandwidth to the world’s most impactful companies, for $14.3 billion with a co-sponsor; separately Digital Colony completed the acquisition of Cogeco Peer 1, a leading Canadian provider of colocation, network connectivity and managed services through its substantial fiber and data center assets, for C$720 million |
• | The Company completed the planned sale and/or monetization of $101 million of assets and net equity proceeds within the Other Equity and Debt segment |
• | The Company achieved approximately 60% of the expected total $50 to $55 million ($45 to $50 million on a cash basis) of the previously announced annual compensation and administrative cost savings on a run rate basis |
• | The Company amended certain terms of its revolving credit facility agreement including a reduction of aggregate revolving commitments from $1 billion to $750 million and a modification of a financial covenant and the borrowing base formula |
• | As of May 7, 2019, the Company had over $850 million of liquidity through availability under its revolving credit facility and cash-on-hand |
Consolidated | CLNY OP | Same Store | |||||||||||||||||||||
NOI | Share NOI(1) | Consolidated NOI | Occupancy %(2) | TTM Lease Coverage(3) | |||||||||||||||||||
($ in millions) | Q1 2019 | Q1 2019 | Q1 2019 | Q4 2018 | Q1 2019 | Q4 2018 | 12/31/18 | 9/30/18 | |||||||||||||||
Senior Housing - Operating | $ | 17.3 | $ | 12.3 | $ | 17.3 | $ | 15.7 | 86.7 | % | 86.8 | % | N/A | N/A | |||||||||
Medical Office Buildings (MOB) | 12.4 | 8.8 | 12.4 | 12.6 | 82.4 | % | 82.3 | % | N/A | N/A | |||||||||||||
Triple-Net Lease: | |||||||||||||||||||||||
Senior Housing | 15.4 | 10.9 | 15.4 | 15.3 | 82.1 | % | 82.1 | % | 1.3x | 1.4x | |||||||||||||
Skilled Nursing Facilities | 25.7 | 18.3 | 25.7 | 25.8 | 82.4 | % | 82.4 | % | 1.2x | 1.2x | |||||||||||||
Hospitals | 5.4 | 3.8 | 5.4 | 4.8 | 58.5 | % | 58.1 | % | 2.3x | 3.4x | (4) | ||||||||||||
Healthcare Total | $ | 76.2 | $ | 54.1 | $ | 76.2 | $ | 74.2 |
(1) | CLNY OP Share NOI represents first quarter 2019 Consolidated NOI multiplied by CLNY OP’s ownership interest as of March 31, 2019. |
(2) | Occupancy % for Senior Housing - Operating represents average during the presented quarter, for MOB’s represents as of last day in the quarter and for other types represents average during the prior quarter. |
(3) | Represents the ratio of the tenant’s/operator’s EBITDAR to cash rent payable to the Company’s Healthcare Real Estate segment on a trailing twelve month basis. |
(4) | September 30, 2018 TTM Lease Coverage included an extraordinary Hospital Quality Assurance Fee received by one of our hospital operators during the fourth quarter of 2017. |
Consolidated | CLNY OP | Same Store | |||||||||||||||||
NOI | Share NOI (1) | Consolidated NOI | Leased %(2) | ||||||||||||||||
($ in millions) | Q1 2019 | Q1 2019 | Q1 2019 | Q4 2018 | 3/31/19 | 12/31/18 | |||||||||||||
Light Industrial(3) | $ | 54.6 | $ | 18.3 | $ | 41.8 | $ | 41.6 | 94.9 | % | 95.6 | % | |||||||
Bulk Industrial(3) | 1.2 | 0.6 | N/A | N/A | N/A | N/A | |||||||||||||
Total Industrial(3) | $ | 55.8 | (3) | $ | 18.9 | (3) | N/A | N/A | N/A | N/A |
(1) | CLNY OP Share NOI represents first quarter 2019 Consolidated NOI multiplied by CLNY OP’s ownership interest as of March 31, 2019. |
(2) | Leased % as of the reported date represents square feet under executed leases, some of which may not have taken occupancy. |
(3) | During the first quarter 2019, this segment’s NOI included partial quarter financial results related to the newly acquired portfolio of light and bulk industrial buildings for the period of February 27, 2019 to March 31, 2019. |
Same Store | |||||||||||||||||||||||||||||||||
Consolidated | CLNY OP Share | Consolidated | Avg. Daily Rate | RevPAR(3) | |||||||||||||||||||||||||||||
NOI before FF&E Reserve(1) | NOI before FF&E Reserve(2) | NOI before FF&E Reserve | Occupancy %(4) | (In dollars)(4) | (In dollars)(4) | ||||||||||||||||||||||||||||
($ in millions) | Q1 2019 | Q1 2019 | Q1 2019 | Q1 2018 | Q1 2019 | Q1 2018 | Q1 2019 | Q1 2018 | Q1 2019 | Q1 2018 | |||||||||||||||||||||||
Marriott | $ | 47.2 | $ | 44.5 | $ | 47.2 | $ | 46.9 | 68.2 | % | 69.2 | % | $ | 130 | $ | 129 | $ | 89 | $ | 89 | |||||||||||||
Hilton | 9.9 | 9.3 | 9.9 | 8.7 | 73.3 | % | 73.8 | % | 126 | 124 | 93 | 91 | |||||||||||||||||||||
Other | 3.5 | 3.3 | 3.5 | 3.6 | 80.4 | % | 78.2 | % | 127 | 127 | 102 | 99 | |||||||||||||||||||||
Total/W.A. | $ | 60.6 | $ | 57.1 | $ | 60.6 | $ | 59.2 | 69.7 | % | 70.4 | % | $ | 129 | $ | 128 | $ | 90 | $ | 90 |
(1) | First quarter 2019 consolidated FF&E reserve was $8.7 million. |
(2) | CLNY OP Share NOI before FF&E Reserve represents first quarter 2019 Consolidated NOI before FF&E Reserve multiplied by CLNY OP’s ownership interest as of March 31, 2019. |
(3) | RevPAR, or revenue per available room, represents a hotel's total guestroom revenue divided by the room count and the number of days in the period being measured. |
(4) | For each metric, data represents average during the presented quarter. |
CLNY OP Share | |||||||||||||||
Undepreciated Carrying Value | |||||||||||||||
March 31, 2019 | December 31, 2018 | ||||||||||||||
($ in millions) | Assets | Equity | Assets | Equity | |||||||||||
Strategic: | |||||||||||||||
GP co-investments | $ | 1,197 | $ | 724 | $ | 1,075 | $ | 684 | |||||||
Interest in NRE | 88 | 88 | 88 | 88 | |||||||||||
Strategic Subtotal | 1,285 | 812 | 1,163 | 772 | |||||||||||
Non-Strategic: | |||||||||||||||
Other Real Estate Equity & Albertsons | 1,372 | 704 | 1,481 | 752 | |||||||||||
Real Estate Debt | 290 | 290 | 297 | 297 | |||||||||||
Net Lease Real Estate Equity | 182 | 74 | 219 | 92 | |||||||||||
CRE Securities and Real Estate Private Equity Funds | 70 | 70 | 70 | 70 | |||||||||||
Non-Strategic Subtotal | 1,914 | 1,138 | 2,067 | 1,211 | |||||||||||
Total Other Equity and Debt | $ | 3,199 | $ | 1,950 | $ | 3,230 | $ | 1,983 |
March 31, 2019 | December 31, 2018 | ||||||||||||
($ in billions) | Amount | % of Grand Total | Amount | % of Grand Total | |||||||||
Balance Sheet (CLNY OP Share): | |||||||||||||
Healthcare | $ | 3.9 | 9.0 | % | $ | 3.9 | 9.1 | % | |||||
Industrial | 1.6 | 3.7 | % | 1.2 | 2.8 | % | |||||||
Hospitality | 3.9 | 9.0 | % | 4.0 | 9.4 | % | |||||||
Other Equity and Debt | 3.2 | 7.4 | % | 3.2 | 7.5 | % | |||||||
CLNC(1) | 2.0 | 4.6 | % | 2.0 | 4.7 | % | |||||||
Balance Sheet Subtotal | 14.6 | 33.7 | % | 14.3 | 33.5 | % | |||||||
Investment Management: | |||||||||||||
Institutional Funds | 9.9 | 22.7 | % | 9.5 | 22.2 | % | |||||||
Retail Companies | 3.5 | 8.1 | % | 3.5 | 8.2 | % | |||||||
Colony Credit Real Estate (NYSE:CLNC)(2) | 3.5 | 8.1 | % | 3.5 | 8.2 | % | |||||||
NorthStar Realty Europe (NYSE:NRE)(3) | 1.6 | 3.7 | % | 1.7 | 4.0 | % | |||||||
Non-Wholly Owned REIM Platforms(4) | 10.3 | 23.7 | % | 10.2 | 23.9 | % | |||||||
Investment Management Subtotal | 28.8 | 66.3 | % | 28.4 | 66.5 | % | |||||||
Grand Total | $ | 43.4 | 100.0 | % | $ | 42.7 | 100.0 | % |
(1) | Represents the Company’s 36% and 37% ownership share of CLNC’s total pro-rata share of assets of $5.5 billion as of March 31, 2019 and December 31, 2018, respectively. |
(2) | Represents third-party 64% and 63% ownership share of CLNC’s total pro-rata share of assets of $5.5 billion as of March 31, 2019 and December 31, 2018, respectively. |
(4) | REIM: Real Estate Investment Management |
March 31, 2019 (unaudited) | December 31, 2018 | |||||||
Assets | ||||||||
Cash and cash equivalents | $ | 321,199 | $ | 461,912 | ||||
Restricted cash | 326,635 | 366,758 | ||||||
Real estate, net | 14,536,041 | 13,619,014 | ||||||
Loans receivable, net | 1,596,673 | 1,659,217 | ||||||
Equity and debt investments | 2,769,616 | 2,543,169 | ||||||
Goodwill | 1,534,561 | 1,534,561 | ||||||
Deferred leasing costs and intangible assets, net | 546,903 | 540,264 | ||||||
Assets held for sale | 786,467 | 941,258 | ||||||
Other assets | 757,752 | 503,317 | ||||||
Due from affiliates | 45,186 | 45,779 | ||||||
Total assets | $ | 23,221,033 | $ | 22,215,249 | ||||
Liabilities | ||||||||
Debt, net | $ | 10,712,788 | $ | 10,039,957 | ||||
Accrued and other liabilities | 1,037,166 | 707,921 | ||||||
Intangible liabilities, net | 141,744 | 159,386 | ||||||
Liabilities related to assets held for sale | 22,435 | 68,217 | ||||||
Dividends and distributions payable | 83,996 | 84,013 | ||||||
Total liabilities | 11,998,129 | 11,059,494 | ||||||
Commitments and contingencies | ||||||||
Redeemable noncontrolling interests | 7,463 | 9,385 | ||||||
Equity | ||||||||
Stockholders’ equity: | ||||||||
Preferred stock, $0.01 par value per share; $1,436,605 liquidation preference; 250,000 shares authorized; 57,464 shares issued and outstanding | 1,407,495 | 1,407,495 | ||||||
Common stock, $0.01 par value per share | ||||||||
Class A, 949,000 shares authorized; 484,775 and 483,347 shares issued and outstanding, respectively | 4,848 | 4,834 | ||||||
Class B, 1,000 shares authorized; 734 shares issued and outstanding | 7 | 7 | ||||||
Additional paid-in capital | 7,610,947 | 7,598,019 | ||||||
Distributions in excess of earnings | (2,176,730 | ) | (2,018,302 | ) | ||||
Accumulated other comprehensive income | 22,138 | 13,999 | ||||||
Total stockholders’ equity | 6,868,705 | 7,006,052 | ||||||
Noncontrolling interests in investment entities | 3,996,206 | 3,779,728 | ||||||
Noncontrolling interests in Operating Company | 350,530 | 360,590 | ||||||
Total equity | 11,215,441 | 11,146,370 | ||||||
Total liabilities, redeemable noncontrolling interests and equity | $ | 23,221,033 | $ | 22,215,249 |
Three Months Ended March 31, | ||||||||
2019 | 2018 | |||||||
Revenues | ||||||||
Property operating income | $ | 540,130 | $ | 554,730 | ||||
Interest income | 46,250 | 63,854 | ||||||
Fee income | 33,500 | 36,842 | ||||||
Other income | 13,023 | 11,238 | ||||||
Total revenues | 632,903 | 666,664 | ||||||
Expenses | ||||||||
Property operating expense | 293,079 | 305,770 | ||||||
Interest expense | 149,516 | 148,889 | ||||||
Investment and servicing expense | 18,979 | 18,653 | ||||||
Transaction costs | 2,504 | 716 | ||||||
Placement fees | 309 | 123 | ||||||
Depreciation and amortization | 150,797 | 144,705 | ||||||
Provision for loan loss | 3,611 | 5,375 | ||||||
Impairment loss | 25,622 | 153,398 | ||||||
Compensation expense | ||||||||
Cash and equity-based compensation | 34,176 | 49,484 | ||||||
Carried interest and incentive fee compensation | 1,051 | 859 | ||||||
Administrative expenses | 24,014 | 24,740 | ||||||
Total expenses | 703,658 | 852,712 | ||||||
Other income (loss) | ||||||||
Gain on sale of real estate assets | 52,301 | 18,444 | ||||||
Other gain (loss), net | (49,077 | ) | 75,256 | |||||
Equity method earnings | 34,065 | 30,117 | ||||||
Equity method earnings—carried interest | 4,422 | 2,148 | ||||||
Loss before income taxes | (29,044 | ) | (60,083 | ) | ||||
Income tax benefit (expense) | (1,111 | ) | 32,808 | |||||
Loss from continuing operations | (30,155 | ) | (27,275 | ) | ||||
Income from discontinued operations | — | 117 | ||||||
Net loss | (30,155 | ) | (27,158 | ) | ||||
Net income (loss) attributable to noncontrolling interests: | ||||||||
Redeemable noncontrolling interests | 1,444 | (696 | ) | |||||
Investment entities | 49,988 | 19,243 | ||||||
Operating Company | (6,611 | ) | (4,378 | ) | ||||
Net loss attributable to Colony Capital, Inc. | (74,976 | ) | (41,327 | ) | ||||
Preferred stock dividends | 27,137 | 31,387 | ||||||
Net loss attributable to common stockholders | $ | (102,113 | ) | $ | (72,714 | ) | ||
Basic loss per share | ||||||||
Loss from continuing operations per basic common share | $ | (0.21 | ) | $ | (0.14 | ) | ||
Net loss per basic common share | $ | (0.21 | ) | $ | (0.14 | ) | ||
Diluted loss per share | ||||||||
Loss from continuing operations per diluted common share | $ | (0.21 | ) | $ | (0.14 | ) | ||
Net loss per diluted common share | $ | (0.21 | ) | $ | (0.14 | ) | ||
Weighted average number of shares | ||||||||
Basic | 478,874 | 530,680 | ||||||
Diluted | 478,874 | 530,680 |
Three Months Ended March 31, 2019 | ||||
Net loss attributable to common stockholders | $ | (102,113 | ) | |
Adjustments for FFO attributable to common interests in Operating Company and common stockholders: | ||||
Net loss attributable to noncontrolling common interests in Operating Company | (6,611 | ) | ||
Real estate depreciation and amortization | 154,402 | |||
Impairment of real estate | 25,622 | |||
Gain from sales of real estate | (55,234 | ) | ||
Less: Adjustments attributable to noncontrolling interests in investment entities | (35,274 | ) | ||
FFO attributable to common interests in Operating Company and common stockholders | (19,208 | ) | ||
Additional adjustments for Core FFO attributable to common interests in Operating Company and common stockholders: | ||||
Gains and losses from sales of depreciable real estate within the Other Equity and Debt segment, net of depreciation, amortization and impairment previously adjusted for FFO (1) | (11,135 | ) | ||
Gains and losses from sales of businesses within the Investment Management segment and impairment write-downs associated with the Investment Management segment | 2,542 | |||
CLNC Core Earnings & NRE Cash Available for Distribution adjustments (2) | (13,988 | ) | ||
Equity-based compensation expense | 7,353 | |||
Straight-line rent revenue and expense | (5,495 | ) | ||
Amortization of acquired above- and below-market lease values, net | (3,866 | ) | ||
Amortization of deferred financing costs and debt premiums and discounts | 18,312 | |||
Unrealized fair value losses on interest rate and foreign currency hedges, and foreign currency remeasurements | 58,143 | |||
Acquisition and merger-related transaction costs | 2,895 | |||
Merger integration and restructuring costs (3) | 769 | |||
Amortization and impairment of investment management intangibles | 8,662 | |||
Non-real estate depreciation and amortization | 1,577 | |||
Amortization of gain on remeasurement of consolidated investment entities | 3,779 | |||
Deferred tax benefit, net | (2,663 | ) | ||
Less: Adjustments attributable to noncontrolling interests in investment entities | 36 | |||
Core FFO attributable to common interests in Operating Company and common stockholders | $ | 47,713 | ||
FFO per common share / common OP unit (4) | $ | (0.04 | ) | |
FFO per common share / common OP unit—diluted (4)(5) | $ | (0.04 | ) | |
Core FFO per common share / common OP unit (4) | $ | 0.09 | ||
Core FFO per common share / common OP unit—diluted (4)(5)(6) | $ | 0.09 | ||
Weighted average number of common OP units outstanding used for FFO and Core FFO per common share and OP unit (4) | 515,494 | |||
Weighted average number of common OP units outstanding used for FFO per common share and OP unit—diluted (4)(5) | 515,494 | |||
Weighted average number of common OP units outstanding used for Core FFO per common share and OP unit—diluted (4)(5)(6) | 519,446 |
(1) | For the three months ended March 31, 2019, net of $43.4 million consolidated or $24.3 million CLNY OP share of depreciation, amortization and impairment charges previously adjusted to calculate FFO and Core Earnings, a non-GAAP measure used by Colony Capital, Inc. prior to its internalization of the manager. |
(2) | Represents adjustments to align the Company’s Core FFO with CLNC’s definition of Core Earnings and NRE’s definition of Cash Available for Distribution (“CAD”) to reflect the Company’s percentage interest in the respective company’s earnings. These adjustments include provisions for loan losses, realized gains and losses plus other differences that are included/excluded in CLNC’s core earnings and NRE’s CAD. |
(3) | Merger integration and restructuring costs represent costs and charges incurred during the integration of Colony, NSAM and NRF and from the corporate restructuring and reorganization plan. These integration and restructuring costs are not reflective of the Company’s core operating performance and the Company does not expect to incur these costs subsequent to the completion of the merger integration and restructuring |
(4) | Calculated based on weighted average shares outstanding including participating securities and assuming the exchange of all common OP units outstanding for common shares. |
(5) | For the three months ended March 31, 2019, excluded in the calculation of diluted FFO and Core FFO per share is the effect of adding back interest expense associated with convertible senior notes and weighted average dilutive common share equivalents for the assumed conversion of the convertible senior notes as the effect of including such interest expense and common share equivalents would be antidilutive. |
(6) | Included in the calculation of diluted Core FFO per share are 3.8 million weighted average performance stock units, which are subject to both a service condition and market condition, and 137,918 weighted average shares of non-participating restricted stock for the three months ended March 31, 2019. |
Three Months Ended March 31, 2019 | ||||||||||||
(In thousands) | Healthcare | Industrial | Hospitality | |||||||||
Total revenues | $ | 145,774 | $ | 82,372 | $ | 196,615 | ||||||
Straight-line rent revenue and amortization of above- and below-market lease intangibles | (5,227 | ) | (3,232 | ) | 310 | |||||||
Interest income | — | (180 | ) | — | ||||||||
Property operating expenses (1) | (64,302 | ) | (22,337 | ) | (136,345 | ) | ||||||
Compensation and administrative expense (1) | — | (784 | ) | — | ||||||||
NOI(2) | $ | 76,245 | $ | 55,839 | $ | 60,580 |
(1) | For healthcare and hospitality, property operating expenses include property management fees paid to third parties. For industrial, there are direct costs of managing the portfolio which are included in compensation expense. |
(2) | For hospitality, NOI is before FF&E Reserve. |
Three Months Ended March 31, 2019 | ||||||||||||
(In thousands) | Healthcare | Industrial | Hospitality | |||||||||
Income (loss) from continuing operations | $ | (7,206 | ) | $ | 24,154 | $ | (26,077 | ) | ||||
Adjustments: | ||||||||||||
Straight-line rent revenue and amortization of above- and below-market lease intangibles | (5,227 | ) | (3,232 | ) | 310 | |||||||
Interest income | — | (180 | ) | — | ||||||||
Interest expense | 47,527 | 14,627 | 42,065 | |||||||||
Transaction, investment and servicing costs | 3,108 | 530 | 1,584 | |||||||||
Depreciation and amortization | 40,131 | 39,445 | 36,248 | |||||||||
Impairment loss | — | — | 3,850 | |||||||||
Compensation and administrative expense | 1,653 | 3,504 | 1,904 | |||||||||
Gain on sale of real estate | — | (22,848 | ) | (139 | ) | |||||||
Other (gain) loss, net | (1,867 | ) | 8 | (1 | ) | |||||||
Income tax (benefit) expense | (1,874 | ) | (169 | ) | 836 | |||||||
NOI(1) | $ | 76,245 | $ | 55,839 | $ | 60,580 |
(1) | For hospitality, NOI is before FF&E Reserve. |
(In thousands) | Income (Loss) From Continuing Operations | |||||||
Healthcare | $ | (7,206 | ) | |||||
Industrial | 24,154 | |||||||
Hospitality | (26,077 | ) | ||||||
CLNC | 5,513 | |||||||
Other Equity and Debt | 59,563 | |||||||
Investment Management | 22,777 | |||||||
Amounts Not Allocated to Segments | (108,879 | ) | ||||||
Total Consolidated | $ | (30,155 | ) |
Cautionary Statement Regarding Forward-Looking Statements |
Colony Capital | Supplemental Financial Report |
Important Note Regarding Non-GAAP Financial Measures |
Colony Capital | Supplemental Financial Report |
Important Note Regarding Non-GAAP Financial Measures |
Colony Capital | Supplemental Financial Report |
Note Regarding CLNY Reportable Segments / Consolidated and OP Share of Consolidated Amounts |
Colony Capital | Supplemental Financial Report |
Table of Contents |
Page | |||
I. | 6-14 | ||
II. | Financial Overview | ||
a. | 15 | ||
b. | 16-17 | ||
III. | Financial Results | ||
a. | 18 | ||
b. | 19 | ||
c. | 20 | ||
d. | 21 | ||
e. | 22 | ||
IV. | Capitalization | ||
a. | 23 | ||
b. | 24 | ||
c. | 25 | ||
d. | 26 | ||
e. | 27 | ||
V. | Healthcare Real Estate | ||
a. | 28 | ||
b. | 29-30 | ||
VI. | Industrial Real Estate | ||
a. | 31 | ||
b. | 32 | ||
Page | |||
VII. | Hospitality Real Estate | ||
a. | 33 | ||
b. | 34 | ||
VIII. | CLNC | ||
a. | 35 | ||
IX. | 36 | ||
a. | 37 | ||
b. | 38 | ||
c. | 39-41 | ||
d. | 42 | ||
X. | Investment Management | ||
a. | 43 | ||
b. | 44 | ||
XI. | Appendices | ||
a. | 46-47 | ||
b. | 48-49 | ||
Colony Capital | Supplemental Financial Report | 5 |
Colony Capital | Supplemental Financial Report | 6 |
Colony Capital | Supplemental Financial Report | 7 |
Colony Capital | Supplemental Financial Report | 8 |
Colony Capital | Supplemental Financial Report | 9 |
Colony Capital | Supplemental Financial Report | 10 |
Colony Capital | Supplemental Financial Report | 11 |
Colony Capital | Supplemental Financial Report | 12 |
Colony Capital | Supplemental Financial Report | 13 |
Colony Capital | Supplemental Financial Report | 14 |
IIa. Financial Overview - Summary Metrics |
($ and shares in thousands, except per share data and as noted; as of or for the three months ended March 31, 2019, unless otherwise noted) (Unaudited) | |||
Financial Data | |||
Net income (loss) attributable to common stockholders | $ | (102,113 | ) |
Net income (loss) attributable to common stockholders per basic share | (0.21 | ) | |
Core FFO(1) | 47,713 | ||
Core FFO per basic share | 0.09 | ||
Q2 2019 dividend per share | 0.11 | ||
Annualized Q2 2019 dividend per share | 0.44 | ||
Balance Sheet, Capitalization and Trading Statistics | |||
Total consolidated assets | $ | 23,221,033 | |
CLNY OP share of consolidated assets | 15,648,517 | ||
Total consolidated debt(2) | 10,913,905 | ||
CLNY OP share of consolidated debt(2) | 7,556,572 | ||
Shares and OP units outstanding as of March 31, 2019 | 516,864 | ||
Shares and OP units outstanding as of May 7, 2019 | 516,958 | ||
Share price as of May 7, 2019 | 5.14 | ||
Market value of common equity & OP units as of May 7, 2019 | 2,657,164 | ||
Liquidation preference of perpetual preferred equity | 1,436,605 | ||
Insider ownership of shares and OP units | 6.3 | % | |
Total Assets Under Management ("AUM") | $ 43.4 billion | ||
Fee Earning Equity Under Management ("FEEUM") | $ 17.8 billion |
(1) | First quarter 2019 Core FFO included net investment losses of $27.7 million. |
(2) | Represents principal balance and excludes debt issuance costs, discounts and premiums. |
Colony Capital | Supplemental Financial Report | 15 |
IIb. Financial Overview - Summary of Segments |
($ in thousands; as of or for the three months ended March 31, 2019, unless otherwise noted) | Consolidated amount | CLNY OP share of consolidated amount | |||||
Healthcare Real Estate | |||||||
Q1 2019 net operating income(1)(2) | $ | 76,245 | $ | 54,058 | |||
Annualized net operating income | 304,980 | 216,232 | |||||
Investment-level non-recourse financing(3) | 3,243,943 | 2,311,226 | |||||
Industrial Real Estate | |||||||
Q1 2019 net operating income(2)(4) | 55,839 | 18,953 | |||||
Annualized net operating income(4) | 223,356 | 75,812 | |||||
Investment-level non-recourse financing(3) | 1,928,287 | 687,887 | |||||
Hospitality Real Estate | |||||||
Q1 2019 NOI before FF&E Reserve(2) | 60,580 | 57,128 | |||||
TTM NOI before FF&E Reserve(5) | 286,867 | 270,516 | |||||
Investment-level non-recourse financing(3) | 2,659,536 | 2,488,663 |
(1) | NOI includes $0.9 million consolidated or $0.6 million CLNY OP share of interest earned related to $50 million consolidated or $35 million CLNY OP share carrying value of healthcare real estate development loans. This interest income is in the Interest Income line item on the Company’s Statement of Operations for the three months ended March 31, 2019. |
(2) | For a reconciliation of net income/(loss) attributable to common stockholders to NOI, please refer to the appendix to this presentation. |
(3) | Represents unpaid principal balance. |
(4) | During the first quarter 2019, this segment’s NOI included partial quarter financial results related to the newly acquired portfolio of light and bulk industrial buildings for the period of February 27, 2019 to March 31, 2019. |
(5) | TTM = trailing twelve month. |
Colony Capital | Supplemental Financial Report | 16 |
IIb. Financial Overview - Summary of Segments (cont’d) |
($ in thousands except as noted; as of or for the three months ended March 31, 2019, unless otherwise noted) | Consolidated amount | CLNY OP share of consolidated amount | |||||
CLNC | |||||||
Net carrying value of 36% interest | $ | 1,027,345 | $ | 1,027,345 | |||
Other Equity and Debt(1) | |||||||
1) Strategic Investments | |||||||
a) GP co-investments - net carrying value | 1,976,082 | 723,610 | |||||
b) Net carrying value of 11% interest in NRE | 88,058 | 88,058 | |||||
2) Net lease real estate equity | |||||||
a) Q1 2019 net operating income | 1,391 | 1,385 | |||||
b) Investment-level non-recourse financing(2) | 108,355 | 107,727 | |||||
3) Other real estate equity | |||||||
a) Undepreciated carrying value of real estate assets(3) | 2,051,249 | 1,044,037 | |||||
b) Investment-level non-recourse financing(2) | 1,272,315 | 666,608 | |||||
c) Carrying value - equity method investments (including Albertsons) | 407,623 | 328,236 | |||||
4) Real estate debt | |||||||
a) Carrying value - consolidated(4) | 354,666 | 251,562 | |||||
b) Investment-level non-recourse financing(2) | — | — | |||||
c) Carrying value - equity method investments | 23,057 | 15,537 | |||||
d) Carrying value - real estate assets (REO within debt portfolio) and other(3) | 38,624 | 23,355 | |||||
5) CRE securities and real estate PE fund investments | |||||||
a) Carrying value | 69,765 | ||||||
Investment Management | |||||||
Third-party AUM ($ in millions) | 28,825 | ||||||
FEEUM ($ in millions) | 17,751 | ||||||
Q1 2019 fee revenue and REIM platform equity method earnings | 41,553 | ||||||
Net Assets | |||||||
Cash and cash equivalents, restricted cash and other assets(5) | 1,363,033 | 1,001,961 | |||||
Accrued and other liabilities and dividends payable(6) | 968,799 | 775,918 | |||||
Net assets | $ | 394,234 | $ | 226,043 |
(1) | Includes assets classified as held for sale on the Company’s financial statements. |
(2) | Represents unpaid principal balance. |
(3) | Includes all components related to real estate assets, including tangible real estate and lease-related intangibles, and excludes accumulated depreciation. |
(4) | Excludes $50 million consolidated or $35 million CLNY OP share carrying value of healthcare real estate development loans. |
(5) | Other assets excludes $11 million consolidated or $7 million CLNY OP share of deferred financing costs and $77 million consolidated or $42 million CLNY OP share of restricted cash which is included in the undepreciated carrying value of the hotel portfolio in Other Real Estate Equity shown on page 38. |
(6) | Accrued and other liabilities exclude $41 million consolidated and CLNY OP share of deferred tax liabilities and other liabilities which are not due in cash and $111 million of derivative liability which is included in the debt of Other GP Co-investments shown on page 37. |
Colony Capital | Supplemental Financial Report | 17 |
IIIa. Financial Results - Consolidated Balance Sheet |
($ in thousands, except per share data) (unaudited) | As of March 31, 2019 | |||
Assets | ||||
Cash and cash equivalents | $ | 321,199 | ||
Restricted cash | 326,635 | |||
Real estate, net | 14,536,041 | |||
Loans receivable, net | 1,596,673 | |||
Equity and debt investments | 2,769,616 | |||
Goodwill | 1,534,561 | |||
Deferred leasing costs and intangible assets, net | 546,903 | |||
Assets held for sale | 786,467 | |||
Other assets | 757,752 | |||
Due from affiliates | 45,186 | |||
Total assets | $ | 23,221,033 | ||
Liabilities | ||||
Debt, net | $ | 10,712,788 | ||
Accrued and other liabilities | 1,037,166 | |||
Intangible liabilities, net | 141,744 | |||
Liabilities related to assets held for sale | 22,435 | |||
Dividends and distributions payable | 83,996 | |||
Total liabilities | 11,998,129 | |||
Commitments and contingencies | ||||
Redeemable noncontrolling interests | 7,463 | |||
Equity | ||||
Stockholders’ equity: | ||||
Preferred stock, $0.01 par value per share; $1,436,605 liquidation preference; 250,000 shares authorized; 57,464 shares issued and outstanding | 1,407,495 | |||
Common stock, $0.01 par value per share | ||||
Class A, 949,000 shares authorized; 484,775 shares issued and outstanding | 4,848 | |||
Class B, 1,000 shares authorized; 734 shares issued and outstanding | 7 | |||
Additional paid-in capital | 7,610,947 | |||
Distributions in excess of earnings | (2,176,730 | ) | ||
Accumulated other comprehensive income | 22,138 | |||
Total stockholders’ equity | 6,868,705 | |||
Noncontrolling interests in investment entities | 3,996,206 | |||
Noncontrolling interests in Operating Company | 350,530 | |||
Total equity | 11,215,441 | |||
Total liabilities, redeemable noncontrolling interests and equity | $ | 23,221,033 |
Colony Capital | Supplemental Financial Report | 18 |
IIIb. Financial Results - Noncontrolling Interests’ Share Balance Sheet |
($ in thousands, except per share data) (unaudited) | As of March 31, 2019 | |||
Assets | ||||
Cash and cash equivalents | $ | 109,802 | ||
Restricted cash | 79,303 | |||
Real estate, net | 5,258,107 | |||
Loans receivable, net | 766,806 | |||
Equity and debt investments | 521,594 | |||
Deferred leasing costs and intangible assets, net | 181,709 | |||
Assets held for sale | 444,749 | |||
Other assets | 210,446 | |||
Total assets | $ | 7,572,516 | ||
Liabilities | ||||
Debt, net | $ | 3,313,367 | ||
Accrued and other liabilities | 192,882 | |||
Intangible liabilities, net | 47,874 | |||
Liabilities related to assets held for sale | 14,724 | |||
Total liabilities | 3,568,847 | |||
Commitments and contingencies | ||||
Redeemable noncontrolling interests | 7,463 | |||
Equity | ||||
Stockholders’ equity: | ||||
Preferred stock, $0.01 par value per share; $1,436,605 liquidation preference; 250,000 shares authorized; 57,464 shares issued and outstanding | — | |||
Common stock, $0.01 par value per share | ||||
Class A, 949,000 shares authorized; 484,775 shares issued and outstanding | — | |||
Class B, 1,000 shares authorized; 734 shares issued and outstanding | — | |||
Additional paid-in capital | — | |||
Distributions in excess of earnings | — | |||
Accumulated other comprehensive income | — | |||
Total stockholders’ equity | — | |||
Noncontrolling interests in investment entities | 3,996,206 | |||
Noncontrolling interests in Operating Company | — | |||
Total equity | 3,996,206 | |||
Total liabilities, redeemable noncontrolling interests and equity | $ | 7,572,516 |
Colony Capital | Supplemental Financial Report | 19 |
IIIc. Financial Results - Consolidated Segment Operating Results |
Three Months Ended March 31, 2019 | ||||||||||||||||||||||||||||||||
($ in thousands) (unaudited) | Healthcare | Industrial | Hospitality | CLNC | Other Equity and Debt | Investment Management | Amounts not allocated to segments | Total | ||||||||||||||||||||||||
Revenues | ||||||||||||||||||||||||||||||||
Property operating income | $ | 144,690 | $ | 81,232 | $ | 196,555 | $ | — | $ | 117,653 | $ | — | $ | — | $ | 540,130 | ||||||||||||||||
Interest income | 931 | 180 | 5 | — | 43,662 | 701 | 771 | 46,250 | ||||||||||||||||||||||||
Fee income | — | — | — | — | — | 33,500 | — | 33,500 | ||||||||||||||||||||||||
Other income | 153 | 960 | 55 | — | 1,373 | 8,276 | 2,206 | 13,023 | ||||||||||||||||||||||||
Total revenues | 145,774 | 82,372 | 196,615 | — | 162,688 | 42,477 | 2,977 | 632,903 | ||||||||||||||||||||||||
Expenses | ||||||||||||||||||||||||||||||||
Property operating expense | 64,302 | 22,337 | 136,345 | — | 70,095 | — | — | 293,079 | ||||||||||||||||||||||||
Interest expense | 47,527 | 14,627 | 42,065 | — | 31,853 | — | 13,444 | 149,516 | ||||||||||||||||||||||||
Investment and servicing expense | 3,108 | 530 | 1,584 | — | 6,496 | 3,956 | 3,305 | 18,979 | ||||||||||||||||||||||||
Transaction costs | — | — | — | — | 773 | 1,731 | — | 2,504 | ||||||||||||||||||||||||
Placement fees | — | — | — | — | — | 309 | — | 309 | ||||||||||||||||||||||||
Depreciation and amortization | 40,131 | 39,445 | 36,248 | — | 24,783 | 8,669 | 1,521 | 150,797 | ||||||||||||||||||||||||
Provision for loan loss | — | — | — | — | 3,611 | — | — | 3,611 | ||||||||||||||||||||||||
Impairment loss | — | — | 3,850 | — | 21,772 | — | — | 25,622 | ||||||||||||||||||||||||
Compensation expense | ||||||||||||||||||||||||||||||||
Cash and equity-based compensation | 1,387 | 2,659 | 1,237 | — | 1,336 | 11,550 | 16,007 | 34,176 | ||||||||||||||||||||||||
Carried interest and incentive compensation | — | — | — | — | — | 1,051 | — | 1,051 | ||||||||||||||||||||||||
Administrative expenses | 266 | 1,629 | 667 | — | 2,301 | 867 | 18,284 | 24,014 | ||||||||||||||||||||||||
Total expenses | 156,721 | 81,227 | 221,996 | — | 163,020 | 28,133 | 52,561 | 703,658 | ||||||||||||||||||||||||
Other income (loss) | ||||||||||||||||||||||||||||||||
Gain on sale of real estate assets | — | 22,848 | 139 | — | 29,314 | — | — | 52,301 | ||||||||||||||||||||||||
Other gain (loss), net | 1,867 | (8 | ) | 1 | — | 8,047 | 55 | (59,039 | ) | (49,077 | ) | |||||||||||||||||||||
Equity method earnings | — | — | — | 5,513 | 24,608 | 3,944 | — | 34,065 | ||||||||||||||||||||||||
Equity method earnings—carried interest | — | — | — | — | — | 4,422 | — | 4,422 | ||||||||||||||||||||||||
Income (loss) before income taxes | (9,080 | ) | 23,985 | (25,241 | ) | 5,513 | 61,637 | 22,765 | (108,623 | ) | (29,044 | ) | ||||||||||||||||||||
Income tax benefit (expense) | 1,874 | 169 | (836 | ) | — | (2,074 | ) | 12 | (256 | ) | (1,111 | ) | ||||||||||||||||||||
Net income (loss) | (7,206 | ) | 24,154 | (26,077 | ) | 5,513 | 59,563 | 22,777 | (108,879 | ) | (30,155 | ) | ||||||||||||||||||||
Net income (loss) attributable to noncontrolling interests: | ||||||||||||||||||||||||||||||||
Redeemable noncontrolling interests | — | — | — | — | 1,444 | — | — | 1,444 | ||||||||||||||||||||||||
Investment entities | 739 | 17,310 | (1,608 | ) | — | 32,648 | 899 | — | 49,988 | |||||||||||||||||||||||
Operating Company | (483 | ) | 416 | (1,488 | ) | 335 | 1,549 | 1,330 | (8,270 | ) | (6,611 | ) | ||||||||||||||||||||
Net income (loss) attributable to Colony Capital, Inc. | (7,462 | ) | 6,428 | (22,981 | ) | 5,178 | 23,922 | 20,548 | (100,609 | ) | (74,976 | ) | ||||||||||||||||||||
Preferred stock dividends | 27,137 | 27,137 | ||||||||||||||||||||||||||||||
Net income (loss) attributable to common stockholders | $ | (7,462 | ) | $ | 6,428 | $ | (22,981 | ) | $ | 5,178 | $ | 23,922 | $ | 20,548 | $ | (127,746 | ) | $ | (102,113 | ) |
Colony Capital | Supplemental Financial Report | 20 |
IIId. Financial Results - Noncontrolling Interests’ Share Segment Operating Results |
Three Months Ended March 31, 2019 | |||||||||||||||||||||||||||||||||
($ in thousands) (unaudited) | Healthcare | Industrial | Hospitality | CLNC | Other Equity and Debt | Investment Management | Amounts not allocated to segments | Total | |||||||||||||||||||||||||
Revenues | — | ||||||||||||||||||||||||||||||||
Property operating income | $ | 40,899 | $ | 52,884 | $ | 11,725 | $ | — | $ | 58,395 | $ | — | $ | — | $ | 163,903 | |||||||||||||||||
Interest income | 283 | 116 | — | — | 27,640 | — | — | 28,039 | |||||||||||||||||||||||||
Fee income | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||
Other income | 46 | — | 6 | — | 382 | — | — | 434 | |||||||||||||||||||||||||
Total revenues | 41,228 | 53,000 | 11,731 | — | 86,417 | — | — | 192,376 | |||||||||||||||||||||||||
Expenses | |||||||||||||||||||||||||||||||||
Property operating expense | 17,767 | 15,001 | 8,260 | — | 33,590 | — | — | 74,618 | |||||||||||||||||||||||||
Interest expense | 13,642 | 9,292 | 2,628 | — | 13,029 | — | — | 38,591 | |||||||||||||||||||||||||
Investment and servicing expense | 833 | 330 | 115 | — | 2,227 | — | — | 3,505 | |||||||||||||||||||||||||
Transaction costs | — | — | — | — | 619 | — | — | 619 | |||||||||||||||||||||||||
Placement fees | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||
Depreciation and amortization | 11,565 | 25,278 | 2,306 | — | 13,313 | — | — | 52,462 | |||||||||||||||||||||||||
Provision for loan loss | — | — | — | — | 1,766 | — | — | 1,766 | |||||||||||||||||||||||||
Impairment loss | — | — | — | — | 14,151 | — | — | 14,151 | |||||||||||||||||||||||||
Compensation expense | |||||||||||||||||||||||||||||||||
Cash and equity-based compensation | 36 | 65 | — | — | 111 | — | — | 212 | |||||||||||||||||||||||||
Carried interest and incentive compensation | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||
Administrative expenses | 77 | 614 | 30 | — | 1,096 | 2 | — | 1,819 | |||||||||||||||||||||||||
Total expenses | 43,920 | 50,580 | 13,339 | — | 79,902 | 2 | — | 187,743 | |||||||||||||||||||||||||
Other income (loss) | |||||||||||||||||||||||||||||||||
Gain on sale of real estate assets | — | 14,785 | — | — | 16,121 | — | — | 30,906 | |||||||||||||||||||||||||
Other gain (loss), net | 567 | (5 | ) | — | — | 1,143 | — | — | 1,705 | ||||||||||||||||||||||||
Equity method earnings (losses) | — | — | — | — | 11,425 | (5 | ) | 11,420 | |||||||||||||||||||||||||
Equity method earnings—carried interest | — | — | — | — | — | 1,217 | — | 1,217 | |||||||||||||||||||||||||
Income (loss) before income taxes | (2,125 | ) | 17,200 | (1,608 | ) | — | 35,204 | 1,210 | — | 49,881 | |||||||||||||||||||||||
Income tax benefit (expense) | 470 | 110 | — | — | (1,112 | ) | — | — | (532 | ) | |||||||||||||||||||||||
Net income (loss) | (1,655 | ) | 17,310 | (1,608 | ) | — | 34,092 | 1,210 | — | 49,349 | |||||||||||||||||||||||
Non-pro rata allocation of income (loss) to NCI | 2,394 | — | — | — | — | (311 | ) | — | 2,083 | ||||||||||||||||||||||||
Net income (loss) attributable to noncontrolling interests | $ | 739 | $ | 17,310 | $ | (1,608 | ) | $ | — | $ | 34,092 | $ | 899 | $ | — | $ | 51,432 |
Colony Capital | Supplemental Financial Report | 21 |
IIIe. Financial Results - Segment Reconciliation of Net Income to FFO & Core FFO |
Three Months Ended March 31, 2019 | ||||||||||||||||||||||||||||||||||||||||
OP pro rata share by segment | Amounts attributable to noncontrolling interests | CLNY consolidated as reported | ||||||||||||||||||||||||||||||||||||||
($ in thousands) (Unaudited) | Healthcare | Industrial | Hospitality | CLNC | Other Equity and Debt | Investment Management | Amounts not allocated to segments | Total OP pro rata share | ||||||||||||||||||||||||||||||||
Net income (loss) attributable to common stockholders | $ | (7,462 | ) | $ | 6,428 | $ | (22,981 | ) | $ | 5,178 | $ | 23,922 | $ | 20,548 | $ | (127,746 | ) | $ | (102,113 | ) | $ | — | $ | (102,113 | ) | |||||||||||||||
Net income (loss) attributable to noncontrolling common interests in Operating Company | (483 | ) | 416 | (1,488 | ) | 335 | 1,549 | 1,330 | (8,270 | ) | (6,611 | ) | — | (6,611 | ) | |||||||||||||||||||||||||
Net income (loss) attributable to common interests in Operating Company and common stockholders | (7,945 | ) | 6,844 | (24,469 | ) | 5,513 | 25,471 | 21,878 | (136,016 | ) | (108,724 | ) | — | (108,724 | ) | |||||||||||||||||||||||||
Adjustments for FFO: | ||||||||||||||||||||||||||||||||||||||||
Real estate depreciation and amortization | 29,833 | 14,118 | 33,942 | 10,262 | 12,548 | 1,889 | — | 102,592 | 51,810 | 154,402 | ||||||||||||||||||||||||||||||
Impairment of real estate | — | — | 3,850 | — | 7,621 | — | — | 11,471 | 14,151 | 25,622 | ||||||||||||||||||||||||||||||
Gain from sales of real estate | — | (8,063 | ) | (139 | ) | — | (16,345 | ) | — | — | (24,547 | ) | (30,687 | ) | (55,234 | ) | ||||||||||||||||||||||||
Less: Adjustments attributable to noncontrolling interests in investment entities | — | — | — | — | — | — | — | — | (35,274 | ) | (35,274 | ) | ||||||||||||||||||||||||||||
FFO | $ | 21,888 | $ | 12,899 | $ | 13,184 | $ | 15,775 | $ | 29,295 | $ | 23,767 | $ | (136,016 | ) | $ | (19,208 | ) | $ | — | $ | (19,208 | ) | |||||||||||||||||
Additional adjustments for Core FFO: | ||||||||||||||||||||||||||||||||||||||||
(Gains) and losses from sales of depreciable real estate within the Other Equity and Debt segment, net of depreciation, amortization and impairment previously adjusted for FFO(1) | — | — | — | — | (8,004 | ) | — | — | (8,004 | ) | (3,131 | ) | (11,135 | ) | ||||||||||||||||||||||||||
(Gains) and losses from sales of businesses within the Investment Management segment and impairment write-downs associated with the Investment Management segment | — | — | — | — | — | 2,542 | — | 2,542 | — | 2,542 | ||||||||||||||||||||||||||||||
CLNC Core Earnings & NRE Cash Available for Distribution adjustments(2) | — | — | — | (12,098 | ) | (1,890 | ) | — | — | (13,988 | ) | — | (13,988 | ) | ||||||||||||||||||||||||||
Equity-based compensation expense | 361 | 749 | 355 | 671 | 444 | 1,944 | 2,829 | 7,353 | — | 7,353 | ||||||||||||||||||||||||||||||
Straight-line rent revenue and expense | (1,682 | ) | (820 | ) | 280 | — | (509 | ) | 45 | (43 | ) | (2,729 | ) | (2,766 | ) | (5,495 | ) | |||||||||||||||||||||||
Amortization of acquired above- and below-market lease values | (1,929 | ) | (339 | ) | (3 | ) | (171 | ) | (62 | ) | — | — | (2,504 | ) | (1,362 | ) | (3,866 | ) | ||||||||||||||||||||||
Amortization of deferred financing costs and debt premiums and discounts | 4,104 | 343 | 3,988 | 52 | 3,390 | 76 | 1,628 | 13,581 | 4,731 | 18,312 | ||||||||||||||||||||||||||||||
Unrealized fair value gains or losses on interest rate and foreign currency hedges, and foreign currency remeasurements | (1,314 | ) | 3 | — | — | 202 | — | 59,269 | 58,160 | (17 | ) | 58,143 | ||||||||||||||||||||||||||||
Acquisition and merger-related transaction costs | — | — | — | 71 | 474 | 1,731 | — | 2,276 | 619 | 2,895 | ||||||||||||||||||||||||||||||
Merger integration and restructuring costs(3) | — | — | — | — | — | — | 769 | 769 | — | 769 | ||||||||||||||||||||||||||||||
Amortization and impairment of investment management intangibles | — | — | — | — | — | 8,662 | — | 8,662 | — | 8,662 | ||||||||||||||||||||||||||||||
Non-real estate depreciation and amortization | — | 49 | — | — | — | 7 | 1,521 | 1,577 | — | 1,577 | ||||||||||||||||||||||||||||||
Amortization of gain on remeasurement of consolidated investment entities | — | — | — | — | 1,889 | — | — | 1,889 | 1,890 | 3,779 | ||||||||||||||||||||||||||||||
Deferred tax (benefit) expense, net | — | — | — | — | — | (2,483 | ) | (180 | ) | (2,663 | ) | — | (2,663 | ) | ||||||||||||||||||||||||||
Less: Adjustments attributable to noncontrolling interests in investment entities | — | — | — | — | — | — | — | — | 36 | 36 | ||||||||||||||||||||||||||||||
Core FFO | $ | 21,428 | $ | 12,884 | $ | 17,804 | $ | 4,300 | $ | 25,229 | $ | 36,291 | $ | (70,223 | ) | $ | 47,713 | $ | — | $ | 47,713 |
(1) | Net of $43.4 million consolidated or $24.3 million CLNY OP share of depreciation, amortization and impairment charges previously adjusted to calculate FFO and Core Earnings, a non-GAAP measure used by Colony Capital, Inc. prior to its internalization of the manager. |
(2) | Represents adjustments to align the Company’s Core FFO with CLNC’s definition of Core Earnings and NRE’s definition of Cash Available for Distribution (“CAD”) to reflect the Company’s percentage interest in the respective company’s earnings. These adjustments include provisions for loan losses, realized gains and losses plus other differences that are included/excluded in CLNC’s core earnings and NRE’s CAD. |
(3) | Merger integration and restructuring costs represent costs and charges incurred during the integration of Colony, NSAM and NRF and from the corporate restructuring and reorganization plan. These integration and restructuring costs are not reflective of the Company’s core operating performance and the Company does not expect to incur these costs subsequent to the completion of the merger integration and restructuring and reorganization plan. The majority of these costs consist of severance, employee costs of those separated or scheduled for separation, system integration and lease terminations. |
Colony Capital | Supplemental Financial Report | 22 |
IVa. Capitalization - Overview |
($ in thousands; except per share data; as of March 31, 2019, unless otherwise noted) | Consolidated amount | CLNY OP share of consolidated amount | |||||||||
Debt (UPB) | |||||||||||
$750,000 Revolving credit facility | $ | — | $ | — | |||||||
Convertible/exchangeable senior notes | 616,105 | 616,105 | |||||||||
Corporate aircraft promissory note | 36,660 | 36,660 | |||||||||
Trust Preferred Securities ("TruPS") | 280,117 | 280,117 | |||||||||
Investment-level debt: | |||||||||||
Healthcare | 3,243,943 | 2,311,226 | |||||||||
Industrial | 1,928,287 | 687,887 | |||||||||
Hospitality | 2,659,536 | 2,488,663 | |||||||||
Other Equity and Debt | 2,149,257 | 1,135,914 | |||||||||
Total investment-level debt | 9,981,023 | 6,623,690 | |||||||||
Total debt | $ | 10,913,905 | $ | 7,556,572 | |||||||
Perpetual preferred equity, redemption value | |||||||||||
Total perpetual preferred equity | $ | 1,436,605 | |||||||||
Common equity as of May 7, 2019 | Price per share | Shares / Units | |||||||||
Class A and B common stock | $ | 5.14 | 485,787 | $ | 2,496,945 | ||||||
OP units | 5.14 | 31,171 | 160,219 | ||||||||
Total market value of common equity | $ | 2,657,164 | |||||||||
Total market capitalization | $ | 11,650,341 |
Colony Capital | Supplemental Financial Report | 23 |
IVb. Capitalization - Investment-Level Debt Overview |
($ in thousands; as of or for the three months ended March 31, 2019, unless otherwise noted) | ||||||||||||||||
Non-recourse investment-level debt overview | ||||||||||||||||
Consolidated | CLNY OP share of consolidated amount | |||||||||||||||
Fixed / Floating | Unpaid principal balance | Unpaid principal balance | Wtd. avg. years remaining to maturity | Wtd. avg. interest rate(1) | ||||||||||||
Healthcare | Fixed | $ | 2,130,999 | $ | 1,486,341 | 1.7 | 4.6 | % | ||||||||
Healthcare | Floating | 1,112,944 | 824,885 | 3.1 | 6.5 | % | ||||||||||
Light Industrial(2) | Fixed | 1,371,514 | 460,094 | 9.2 | 3.8 | % | ||||||||||
Light Industrial(2) | Floating | 321,773 | 107,943 | 4.5 | 3.9 | % | ||||||||||
Bulk Industrial | Floating | 235,000 | 119,850 | 4.9 | 4.5 | % | ||||||||||
Hospitality | Fixed | 12,559 | 12,245 | 2.4 | 13.0 | % | ||||||||||
Hospitality | Floating | 2,646,977 | 2,476,418 | 3.8 | 5.6 | % | ||||||||||
Other Equity and Debt | ||||||||||||||||
Net lease real estate equity | Fixed | 108,355 | 107,727 | 3.7 | 5.0 | % | ||||||||||
Other real estate equity | Fixed | 72,154 | 21,347 | 3.5 | 3.2 | % | ||||||||||
Other real estate equity | Floating | 1,200,161 | 645,261 | 3.2 | 5.1 | % | ||||||||||
GP Co-investments | Floating | 767,712 | 361,405 | 2.8 | 4.2 | % | ||||||||||
GP Co-investments | Fixed | 875 | 174 | 4.3 | 2.4 | % | ||||||||||
Total investment-level debt | $ | 9,981,023 | $ | 6,623,690 | 3.5 | 5.2 | % | |||||||||
Fixed / Floating Summary | ||||||||||||||||
Fixed | $ | 3,696,456 | $ | 2,087,928 | ||||||||||||
Floating | 6,284,567 | 4,535,762 | ||||||||||||||
Total investment-level debt | $ | 9,981,023 | $ | 6,623,690 |
(1) | Based on 1-month LIBOR of 2.50% and 3-month LIBOR of 2.60% for floating rate debt. |
(2) | $300 million consolidated or $101 million CLNY OP share of Light Industrial floating rate (LIBOR plus 135bps) term debt is categorized as fixed rate debt to reflect interest rate swaps resulting in an effective fixed rate of 3.50%. |
Colony Capital | Supplemental Financial Report | 24 |
IVc. Capitalization - Revolving Credit Facility Overview |
($ in thousands, except as noted; as of March 31, 2019) | ||||
Revolving credit facility | ||||
Maximum principal amount | $ | 750,000 | ||
Amount outstanding | — | |||
Initial maturity | January 11, 2021 | |||
Fully-extended maturity | January 10, 2022 | |||
Interest rate | LIBOR + 2.25% | |||
Financial covenants as defined in the Credit Agreement: | Covenant level | |||
Consolidated Tangible Net Worth | Minimum $4,550 million | |||
Consolidated Fixed Charge Coverage Ratio(1) | Minimum 1.30 to 1.00 | |||
Interest Coverage Ratio(2) | Minimum 3.00 to 1.00 | |||
Consolidated Leverage Ratio | Maximum 0.65 to 1.00 | |||
Company status: As of March 31, 2019, CLNY is meeting all required covenant threshold levels |
(1) | In the event the Fixed Charge Coverage Ratio is between 1.50 and 1.30 to 1.00, the borrowing base formula will be discounted by 10%. |
(2) | Interest Coverage Ratio represents the ratio of the sum of (1) earnings from borrowing base assets and (2) certain investment management earnings divided by the greater of (a) actual interest expense on the revolving credit facility and (b) the average balance of the facility multiplied by 7.0% for the applicable quarter. |
Colony Capital | Supplemental Financial Report | 25 |
IVd. Capitalization - Corporate Securities Overview |
($ in thousands, except per share data; as of March 31, 2019, unless otherwise noted) | ||||||||||||||||||||
Convertible/exchangeable debt | ||||||||||||||||||||
Description | Outstanding principal | Final due date | Interest rate | Conversion price (per share of common stock) | Conversion ratio | Conversion shares | Redemption date | |||||||||||||
5.0% Convertible senior notes | $ | 200,000 | April 15, 2023 | 5.00% fixed | $ | 15.76 | 63.4700 | 12,694 | On or after April 22, 2020(1) | |||||||||||
3.875% Convertible senior notes | 402,500 | January 15, 2021 | 3.875% fixed | 16.57 | 60.3431 | 24,288 | On or after January 22, 2019(1) | |||||||||||||
5.375% Exchangeable senior notes | 13,605 | June 15, 2033 | 5.375% fixed | 12.04 | 83.0837 | 1,130 | On or after June 15, 2020(1) | |||||||||||||
Total convertible debt | $ | 616,105 |
TruPS | ||||||||
Description | Outstanding principal | Final due date | Interest rate | |||||
Trust I | $ | 41,240 | March 30, 2035 | 3M L + 3.25% | ||||
Trust II | 25,780 | June 30, 2035 | 3M L + 3.25% | |||||
Trust III | 41,238 | January 30, 2036 | 3M L + 2.83% | |||||
Trust IV | 50,100 | June 30, 2036 | 3M L + 2.80% | |||||
Trust V | 30,100 | September 30, 2036 | 3M L + 2.70% | |||||
Trust VI | 25,100 | December 30, 2036 | 3M L + 2.90% | |||||
Trust VII | 31,459 | April 30, 2037 | 3M L + 2.50% | |||||
Trust VIII | 35,100 | July 30, 2037 | 3M L + 2.70% | |||||
Total TruPS | $ | 280,117 |
Perpetual preferred stock | |||||||||
Description | Liquidation preference | Shares outstanding (In thousands) | Callable period | ||||||
Series B 8.25% cumulative redeemable perpetual preferred stock | $ | 152,855 | 6,114 | Callable | |||||
Series E 8.75% cumulative redeemable perpetual preferred stock | 250,000 | 10,000 | On or after May 15, 2019 | ||||||
Series G 7.5% cumulative redeemable perpetual preferred stock | 86,250 | 3,450 | On or after June 19, 2019 | ||||||
Series H 7.125% cumulative redeemable perpetual preferred stock | 287,500 | 11,500 | On or after April 13, 2020 | ||||||
Series I 7.15% cumulative redeemable perpetual preferred stock | 345,000 | 13,800 | On or after June 5, 2022 | ||||||
Series J 7.125% cumulative redeemable perpetual preferred stock | 315,000 | 12,600 | On or after September 22, 2022 | ||||||
Total preferred stock | $ | 1,436,605 | 57,464 |
(1) | Callable at principal amount only if CLNY common stock has traded at least 130% of the conversion price for 20 of 30 consecutive trading days. |
Colony Capital | Supplemental Financial Report | 26 |
IVe. Capitalization - Debt Maturity and Amortization Schedules |
($ in thousands; as of March 31, 2019) | Payments due by period(1) | |||||||||||||||||||||||
Consolidated debt | Fixed / Floating | 2019 | 2020 | 2021 | 2022 | 2023 and after | Total | |||||||||||||||||
$750,000 Revolving credit facility | Floating | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | |||||||||||
Convertible/exchangeable senior notes | Fixed | — | — | 402,500 | — | 213,605 | 616,105 | |||||||||||||||||
Corporate aircraft promissory note | Fixed | 1,603 | 2,243 | 2,359 | 2,480 | 27,975 | 36,660 | |||||||||||||||||
TruPS | Floating | — | — | — | — | 280,117 | 280,117 | |||||||||||||||||
Investment-level debt: | ||||||||||||||||||||||||
Healthcare | Fixed | 1,725,019 | 6,809 | 8,083 | 9,068 | 382,020 | 2,130,999 | |||||||||||||||||
Healthcare | Floating | 373,270 | 52,612 | 399,606 | 150,757 | 136,699 | 1,112,944 | |||||||||||||||||
Light Industrial(2) | Fixed | 632 | 875 | 2,689 | 6,736 | 1,360,582 | 1,371,514 | |||||||||||||||||
Light Industrial(2) | Floating | — | — | — | 1 | 321,772 | 321,773 | |||||||||||||||||
Bulk Industrial | Floating | — | — | — | — | 235,000 | 235,000 | |||||||||||||||||
Hospitality | Fixed | — | — | 12,559 | — | — | 12,559 | |||||||||||||||||
Hospitality | Floating | — | 132,250 | 207,927 | 1,630,000 | 676,800 | 2,646,977 | |||||||||||||||||
Other Equity and Debt | Fixed | 38,652 | 14,519 | 25,949 | 19,595 | 82,668 | 181,383 | |||||||||||||||||
Other Equity and Debt | Floating | 224,560 | 73,268 | 271,792 | 1,036,493 | 361,761 | 1,967,874 | |||||||||||||||||
Total consolidated debt | $ | 2,363,736 | $ | 282,576 | $ | 1,333,464 | $ | 2,855,130 | $ | 4,078,999 | $ | 10,913,905 | ||||||||||||
Pro rata debt | Fixed / Floating | 2019 | 2020 | 2021 | 2022 | 2023 and after | Total | |||||||||||||||||
$750,000 Revolving credit facility | Floating | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | |||||||||||
Convertible/exchangeable senior notes | Fixed | — | — | 402,500 | — | 213,605 | 616,105 | |||||||||||||||||
Corporate aircraft promissory note | Fixed | 1,603 | 2,243 | 2,359 | 2,480 | 27,975 | 36,660 | |||||||||||||||||
TruPS | Floating | — | — | — | — | 280,117 | 280,117 | |||||||||||||||||
Investment-level debt: | ||||||||||||||||||||||||
Healthcare | Fixed | 1,201,303 | 4,781 | 5,675 | 6,366 | 268,216 | 1,486,341 | |||||||||||||||||
Healthcare | Floating | 264,354 | 42,577 | 316,919 | 105,837 | 95,198 | 824,885 | |||||||||||||||||
Light Industrial(2) | Fixed | 212 | 293 | 902 | 2,260 | 456,427 | 460,094 | |||||||||||||||||
Light Industrial(2) | Floating | — | — | — | — | 107,943 | 107,943 | |||||||||||||||||
Bulk Industrial | Floating | — | — | — | — | 119,850 | 119,850 | |||||||||||||||||
Hospitality | Fixed | — | — | 12,245 | — | — | 12,245 | |||||||||||||||||
Hospitality | Floating | — | 132,250 | 202,729 | 1,464,639 | 676,800 | 2,476,418 | |||||||||||||||||
Other Equity and Debt | Fixed | 29,431 | 5,254 | 9,122 | 6,746 | 78,695 | 129,248 | |||||||||||||||||
Other Equity and Debt | Floating | 81,910 | 28,215 | 245,475 | 528,496 | 122,570 | 1,006,666 | |||||||||||||||||
Total pro rata debt | $ | 1,578,813 | $ | 215,613 | $ | 1,197,926 | $ | 2,116,824 | $ | 2,447,396 | $ | 7,556,572 |
(1) | Based on initial maturity dates or extended maturity dates to the extent criteria are met and the extension option is at the borrower’s discretion. |
(2) | $300 million consolidated or $101 million CLNY OP share of Light Industrial floating rate (LIBOR plus 135bps) term debt is categorized as fixed rate debt to reflect interest rate swaps resulting in an effective fixed rate of 3.50%. |
Colony Capital | Supplemental Financial Report | 27 |
Va. Healthcare Real Estate - Summary Metrics and Operating Results |
($ in thousands; as of or for the three months ended March 31, 2019, unless otherwise noted) | Consolidated amount | CLNY OP share of consolidated amount(1) | ||||||
Net operating income | ||||||||
Net operating income: | ||||||||
Senior Housing - Operating | $ | 17,335 | $ | 12,291 | ||||
Medical Office Buildings | 12,424 | 8,809 | ||||||
Triple-Net Lease: | ||||||||
Senior Housing(2) | 15,379 | 10,904 | ||||||
Skilled Nursing Facilities | 25,744 | 18,252 | ||||||
Hospitals | 5,363 | 3,802 | ||||||
Total net operating income | $ | 76,245 | $ | 54,058 |
Portfolio overview | Total number of buildings | Capacity | % Occupied(3) | TTM Lease Coverage(4) | WA Remaining Lease Term | ||||||||
Senior Housing - Operating | 108 | 6,388 units | 86.7 | % | N/A | N/A | |||||||
Medical Office Buildings | 108 | 3.8 million sq. ft. | 82.4 | % | N/A | 4.5 | |||||||
Triple-Net Lease: | |||||||||||||
Senior Housing | 84 | 4,231 units | 82.1 | % | 1.3x | 11.4 | |||||||
Skilled Nursing Facilities | 99 | 11,829 beds | 82.4 | % | 1.2x | 5.7 | |||||||
Hospitals | 14 | 872 beds | 58.5 | % | 2.3x | 9.7 | |||||||
Total | 413 |
Same store financial/operating results related to the segment | |||||||||||||||||||||
% Occupied(3) | TTM Lease Coverage(4) | NOI | |||||||||||||||||||
Q1 2019 | Q4 2018 | 12/31/2018 | 9/30/2018 | Q1 2019 | Q4 2018 | % Change | |||||||||||||||
Senior Housing - Operating | 86.7 | % | 86.8 | % | N/A | N/A | $ | 17,335 | $ | 15,698 | 10.4 | % | |||||||||
Medical Office Buildings | 82.4 | % | 82.3 | % | N/A | N/A | 12,424 | 12,618 | (1.5 | )% | |||||||||||
Triple-Net Lease: | |||||||||||||||||||||
Senior Housing | 82.1 | % | 82.1 | % | 1.3x | 1.4x | 15,379 | 15,311 | 0.4 | % | |||||||||||
Skilled Nursing Facilities | 82.4 | % | 82.4 | % | 1.2x | 1.2x | 25,744 | 25,837 | (0.4 | )% | |||||||||||
Hospitals | 58.5 | % | 58.1 | % | 2.3x | 3.4x | (5) | 5,363 | 4,786 | 12.1 | % | ||||||||||
Total | $ | 76,245 | $ | 74,250 | 2.7 | % |
(1) | CLNY OP Share represents Consolidated NOI multiplied by CLNY OP's interest of 71% as of March 31, 2019. |
(2) | NOI includes $0.9 million consolidated or $0.6 million CLNY OP share of interest earned related to $50 million consolidated or $35 million CLNY OP share carrying value of healthcare real estate development loans. This interest income is in the Interest Income line item on the Company’s Statement of Operations for the three months ended March 31, 2019. For a reconciliation of net income/(loss) attributable to common stockholders to NOI, please refer to the appendix to this presentation. |
(3) | Occupancy % for Senior Housing - Operating represents average of the presented quarter, MOB’s is as of last day in the quarter and for Triple-Net Lease represents average of the prior quarter. Occupancy represents real estate property operator’s patient occupancy for all types except MOB. |
(4) | Represents the ratio of the tenant's/operator's EBITDAR to cash rent payable to the Company's Healthcare Real Estate segment on a trailing twelve month basis. Refer to Important Notes Regarding Non-GAAP Financial Measures and Definitions pages in this presentation for additional information regarding the use of tenant/operator EBITDAR. |
(5) | September 30, 2018 TTM Lease Coverage included an extraordinary Hospital Quality Assurance Fee received by one of our hospital operators during the fourth quarter of 2017. |
Colony Capital | Supplemental Financial Report | 28 |
Vb. Healthcare Real Estate - Portfolio Overview |
(As of or for the three months ended March 31, 2019, unless otherwise noted) | |||||||||||||||
Triple-Net Lease Coverage(1) | % of Triple-Net Lease TTM NOI as of December 31, 2018 | ||||||||||||||
December 31, 2018 TTM Lease Coverage | # of Leases | Senior Housing | Skilled Nursing Facilities & Hospitals | % Triple-Net Lease NOI | WA Remaining Lease Term | ||||||||||
Less than 0.99x | 7 | 6 | % | 18 | % | 24 | % | 5 yrs | |||||||
1.00x - 1.09x | 1 | — | % | 10 | % | 10 | % | 8 yrs | |||||||
1.10x - 1.19x | 1 | 4 | % | — | % | 4 | % | 9 yrs | |||||||
1.20x - 1.29x | 1 | — | % | 11 | % | 11 | % | 9 yrs | |||||||
1.30x - 1.39x | 3 | 20 | % | 9 | % | 29 | % | 12 yrs | |||||||
1.40x - 1.49x | — | — | % | — | % | — | % | — | |||||||
1.50x and greater | 4 | 2 | % | 20 | % | 22 | % | 5 yrs | |||||||
Total / W.A. | 17 | 32 | % | 68 | % | 100 | % | 8 yrs |
Revenue Mix(2) | December 31, 2018 TTM | ||||||||
Private Pay | Medicare | Medicaid | |||||||
Senior Housing - Operating | 86 | % | 4 | % | 10 | % | |||
Medical Office Buildings | 100 | % | — | % | — | % | |||
Triple-Net Lease: | |||||||||
Senior Housing | 66 | % | — | % | 34 | % | |||
Skilled Nursing Facilities | 25 | % | 20 | % | 55 | % | |||
Hospitals | 14 | % | 42 | % | 44 | % | |||
W.A. | 59 | % | 10 | % | 31 | % |
(1) | Represents the ratio of the tenant's/operator's EBITDAR to cash rent payable to the Company's Healthcare Real Estate segment on a trailing twelve month basis. Refer to Important Notes Regarding Non-GAAP Financial Measures and Definitions pages in this presentation for additional information regarding the use of tenant/operator EBITDAR. Represents leases with EBITDAR coverage in each listed range. Excludes interest income associated with triple-net lease senior housing and hospital types. Caring Homes (U.K.) lease (EBITDAR) coverage includes additional collateral provided by the operator. |
(2) | Revenue mix represents percentage of revenues derived from private, Medicare and Medicaid payor sources. The payor source percentages for the hospital category excludes two operating partners, whom do not track or report payor source data and totals approximately one-third of NOI in the hospital category. Overall percentages are weighted by NOI exposure in each category. |
Colony Capital | Supplemental Financial Report | 29 |
Vb. Healthcare Real Estate - Portfolio Overview (cont’d) |
($ in thousands; as of or for the three months ended March 31, 2019, unless otherwise noted) | |||||||
Top 10 Geographic Locations by NOI | |||||||
Number of buildings | NOI | ||||||
United Kingdom | 45 | $ | 10,021 | ||||
Indiana | 55 | 6,966 | |||||
Illinois | 35 | 6,932 | |||||
Florida | 27 | 6,613 | |||||
Pennsylvania | 11 | 4,924 | |||||
Texas | 31 | 4,749 | |||||
Georgia | 22 | 4,530 | |||||
Ohio | 35 | 4,350 | |||||
Oregon | 31 | 4,245 | |||||
California | 14 | 4,078 | |||||
Total | 306 | $ | 57,408 |
Top 10 Operators/Tenants by NOI | ||||||||||||||||
Property Type/Primary Segment | Number of buildings | NOI | % Occupied | TTM Lease Coverage | WA Remaining Lease Term | |||||||||||
Senior Lifestyle | Sr. Housing / RIDEA | 81 | $ | 14,266 | 87.6 | % | N/A | N/A | ||||||||
Caring Homes (U.K.)(1) | Sr. Housing / NNN | 45 | 10,021 | 87.3 | % | 1.4x | 15 yrs | |||||||||
Sentosa | SNF / NNN | 11 | 4,924 | 85.0 | % | 1.2x | 9 yrs | |||||||||
Wellington Healthcare | SNF / NNN | 11 | 4,030 | 90.0 | % | 1.1x | 8 yrs | |||||||||
Millers | SNF / NNN | 28 | 3,925 | 70.9 | % | 2.1x | N/A | |||||||||
Frontier | Sr. Housing / RIDEA / NNN | 20 | 3,459 | 83.1 | % | N/A | N/A | |||||||||
Opis | SNF / NNN | 11 | 2,857 | 91.1 | % | 1.4x | 5 yrs | |||||||||
Grace | SNF / NNN | 9 | 2,653 | 81.0 | % | 0.9x | 2 yrs | |||||||||
Consulate | SNF / NNN | 10 | 2,435 | 86.0 | % | 0.9x | 9 yrs | |||||||||
Avanti Hospital Systems | Hospital | 5 | 2,361 | 53.0 | % | 3.2x | 9 yrs | |||||||||
Total | 231 | $ | 50,931 |
(1) | Caring Homes (U.K.) lease (EBITDAR) coverage includes additional collateral provided by the operator. |
Colony Capital | Supplemental Financial Report | 30 |
VIa. Industrial Real Estate - Summary Metrics and Operating Results |
($ in thousands; as of or for the three months ended March 31, 2019, unless otherwise noted) | Consolidated amount(1) | CLNY OP share of consolidated amount(1) | ||||||
Net operating income | ||||||||
Light Industrial(2) | $ | 54,579 | $ | 18,310 | ||||
Bulk Industrial(2) | 1,260 | 643 | ||||||
Total Industrial(2) | $ | 55,839 | $ | 18,953 |
Portfolio overview | Light | Bulk | Total | ||||||
Total number of buildings | 413 | 6 | 419 | ||||||
Rentable square feet (thousands) | 53,881 | 4,183 | 58,064 | ||||||
% leased at end of period | 91.8 | % | 67.4 | % | |||||
Average remaining lease term | 3.8 | 12.0 |
Light industrial same store financial/operating results | Q1 2019 | Q4 2018 | % Change | ||||||||
Same store number of buildings | 314 | 314 | — | ||||||||
% leased at end of period | 94.9 | % | 95.6 | % | (0.7 | )% | |||||
NOI | $ | 41,836 | $ | 41,593 | 0.6 | % |
Recent acquisitions & dispositions | Acquisition / Disposition date | Number of buildings | Rentable square feet (thousands) | % leased | Purchase price / Sales price | ||||||||||
Q1 2019 acquisitions: | |||||||||||||||
Las Vegas industrial portfolio | 1/24/2019 | 2 | 424 | 92.5 | % | $ | 38,000 | ||||||||
New Jersey industrial property | 1/31/2019 | 1 | 271 | 100.0 | % | 62,000 | |||||||||
National light industrial portfolio | 2/27/2019 | 44 | 6,916 | 77.6 | % | 682,950 | |||||||||
National bulk industrial portfolio | 2/27/2019 | 6 | 4,183 | 67.4 | % | 371,600 | |||||||||
Land for development | Various | N/A | N/A | N/A | 5,609 | ||||||||||
Total / W.A. | 53 | 11,794 | 75.0 | % | $ | 1,160,159 | |||||||||
Q1 2019 dispositions: | |||||||||||||||
National light industrial portfolio | 2/20/2019 | 34 | 2,256 | N/A | $ | 135,667 | |||||||||
Total / W.A. | 34 | 2,256 | N/A | $ | 135,667 | ||||||||||
Q2 2019 acquisitions: | |||||||||||||||
Land for development | Various | N/A | N/A | N/A | $ | 15,150 | |||||||||
Total / W.A. | N/A | N/A | N/A | $ | 15,150 |
(1) | CLNY OP Share represents Consolidated NOI multiplied by CLNY OP's light industrial portfolio interest of 34% and bulk industrial portfolio interest of 51% as of March 31, 2019. For a reconciliation of net income/(loss) attributable to common stockholders to NOI, please refer to the appendix to this presentation. |
(2) | During the first quarter 2019, this segment’s NOI included partial quarter financial results related to the newly acquired portfolio of light and bulk industrial buildings for the period of February 27, 2019 to March 31, 2019. |
Colony Capital | Supplemental Financial Report | 31 |
VIb. Industrial Real Estate - Portfolio Overview |
($ in thousands; as of or for the three months ended March 31, 2019, unless otherwise noted) | |||||||||||||
Top 10 Geographic Locations by NOI - Light Industrial Portfolio | Number of buildings | Rentable square feet (thousands) | NOI | % leased at end of period | |||||||||
Atlanta | 53 | 6,859 | $ | 7,573 | 98.9 | % | |||||||
Dallas | 63 | 6,982 | 7,195 | 95.7 | % | ||||||||
Orlando | 17 | 2,851 | 3,720 | 98.8 | % | ||||||||
Chicago | 37 | 5,128 | 3,583 | 85.3 | % | ||||||||
New Jersey, South / Philadelphia | 26 | 3,236 | 3,441 | 90.6 | % | ||||||||
Minneapolis | 18 | 2,814 | 3,421 | 96.8 | % | ||||||||
Phoenix | 27 | 3,100 | 3,405 | 97.0 | % | ||||||||
Baltimore | 23 | 2,956 | 3,193 | 93.7 | % | ||||||||
Jacksonville | 11 | 2,011 | 2,188 | 99.9 | % | ||||||||
Houston | 18 | 1,604 | 1,990 | 83.6 | % | ||||||||
Total / W.A. | 293 | 37,541 | $ | 39,709 | 94.4 | % |
Top 10 Tenant Base by Industry - Light Industrial Portfolio | ||||||
Industry | Total leased square feet (thousands) | % of total | ||||
Warehousing & Transportation | 21,274 | 43.0 | % | |||
Manufacturing | 8,970 | 18.2 | % | |||
Professional, Scientific & Technical Services | 4,521 | 9.1 | % | |||
Wholesale Trade | 4,296 | 8.7 | % | |||
Health & Science | 3,300 | 6.7 | % | |||
Media & Information | 2,562 | 5.2 | % | |||
Construction & Contractors | 2,123 | 4.3 | % | |||
Retail Trade | 1,623 | 3.3 | % | |||
Entertainment & Recreation | 679 | 1.4 | % | |||
Public Administration & Government | 67 | 0.1 | % | |||
Total | 49,415 | 100.0 | % |
Colony Capital | Supplemental Financial Report | 32 |
VIIa. Hospitality Real Estate - Summary Metrics and Operating Results |
($ in thousands; as of or for the three months ended March 31, 2019, unless otherwise noted) | CLNY OP share of consolidated amount(1) | |||||||
NOI before FF&E Reserve | Consolidated amount | |||||||
NOI before FF&E Reserve: | ||||||||
Select Service | $ | 34,181 | $ | 32,233 | ||||
Extended Stay | 22,847 | 21,545 | ||||||
Full Service | 3,552 | 3,350 | ||||||
Total NOI before FF&E Reserve(2) | $ | 60,580 | $ | 57,128 |
Portfolio overview by type | ||||||||||||||||||||||||
Number of hotels | Number of rooms | Avg. qtr. % occupancy | Avg. daily rate (ADR) | RevPAR | Q1 2019 NOI before FF&E Reserve | NOI before FF&E Reserve margin | ||||||||||||||||||
Select service | 97 | 13,194 | 67.1 | % | $ | 126 | $ | 84 | $ | 34,181 | 30.8 | % | ||||||||||||
Extended stay | 66 | 7,936 | 74.1 | % | 130 | 96 | 22,847 | 32.3 | % | |||||||||||||||
Full service | 4 | 966 | 70.0 | % | 171 | 120 | 3,552 | 24.5 | % | |||||||||||||||
Total / W.A. | 167 | 22,096 | 69.7 | % | $ | 129 | $ | 90 | $ | 60,580 | 30.8 | % |
Same store financial/operating results related to the segment by brand | |||||||||||||||||||||||||||||||||
Avg. qtr. % occupancy | Avg. daily rate (ADR) | RevPAR | NOI before FF&E Reserve | ||||||||||||||||||||||||||||||
Brand | Q1 2019 | Q1 2018 | Q1 2019 | Q1 2018 | Q1 2019 | Q1 2018 | Q1 2019 | Q1 2018 | % Change | ||||||||||||||||||||||||
Marriott | 68.2 | % | 69.2 | % | $ | 130 | $ | 129 | $ | 89 | $ | 89 | $ | 47,172 | $ | 46,883 | 0.6 | % | |||||||||||||||
Hilton | 73.3 | % | 73.8 | % | 126 | 124 | 93 | 91 | 9,857 | 8,746 | 12.7 | % | |||||||||||||||||||||
Other | 80.4 | % | 78.2 | % | 127 | 127 | 102 | 99 | 3,551 | 3,563 | (0.3 | )% | |||||||||||||||||||||
Total / W.A. | 69.7 | % | 70.4 | % | $ | 129 | $ | 128 | $ | 90 | $ | 90 | $ | 60,580 | $ | 59,192 | 2.4 | % |
(1) | CLNY OP Share represents Consolidated NOI before FF&E Reserve multiplied by CLNY OP's interest of 94% as of March 31, 2019. |
(2) | Q1 2019 FF&E reserve was $8.7 million consolidated or $8.2 million CLNY OP share. For a reconciliation of net income/(loss) attributable to common stockholders to NOI please refer to the appendix to this presentation. |
Colony Capital | Supplemental Financial Report | 33 |
VIIb. Hospitality Real Estate - Portfolio Overview |
($ in thousands; as of March 31, 2019, unless otherwise noted) | |||||||||||||||||||
Top 10 Geographic Locations by NOI before FF&E Reserve | Number of hotels | Number of rooms | Number of rooms-select service | Number of rooms-extended stay | Number of rooms-full service | NOI before FF&E Reserve | |||||||||||||
Florida | 12 | 2,065 | 1,187 | 291 | 587 | $ | 13,013 | ||||||||||||
California | 18 | 2,254 | 1,243 | 1,011 | — | 10,990 | |||||||||||||
Texas | 28 | 3,230 | 1,952 | 1,278 | — | 7,466 | |||||||||||||
North Carolina | 7 | 981 | 831 | 150 | — | 3,138 | |||||||||||||
Georgia | 7 | 974 | 694 | 280 | — | 3,118 | |||||||||||||
New Jersey | 12 | 1,884 | 718 | 942 | 224 | 2,493 | |||||||||||||
Washington | 5 | 664 | 160 | 504 | — | 2,484 | |||||||||||||
Virginia | 11 | 1,473 | 1,210 | 263 | — | 2,441 | |||||||||||||
Arizona | 3 | 418 | 298 | 120 | — | 2,216 | |||||||||||||
Michigan | 6 | 809 | 601 | 208 | — | 1,894 | |||||||||||||
Total / W.A. | 109 | 14,752 | 8,894 | 5,047 | 811 | $ | 49,253 |
Colony Capital | Supplemental Financial Report | 34 |
VIIIa. CLNC |
($ in thousands, except as noted and per share data; as of March 31, 2019, unless otherwise noted) | Consolidated amount | CLNY OP share of consolidated amount | ||||||
Colony Credit Real Estate, Inc. (NYSE: CLNC) | ||||||||
CLNY OP interest in CLNC as of May 7, 2019 | 36.4 | % | 36.4 | % | ||||
CLNC shares beneficially owned by OP and common stockholders | 48.0 million | 48.0 million | ||||||
CLNC share price as of May 7, 2019 | $ | 15.68 | $ | 15.68 | ||||
Total market value of CLNC shares | $ | 752,085 | $ | 752,085 | ||||
Net carrying value - CLNC | $ | 1,027,345 | $ | 1,027,345 | ||||
Colony Capital | Supplemental Financial Report | 35 |
IX. Other Equity and Debt Summary |
($ in thousands; as of March 31, 2019) | Consolidated amount | CLNY OP share of consolidated amount | |||||||||||||
Assets | Equity | Assets | Equity | ||||||||||||
Strategic(1) | |||||||||||||||
GP co-investments | $ | 2,855,958 | $ | 1,976,082 | $ | 1,196,473 | $ | 723,611 | |||||||
11% interest in NRE | 88,058 | 88,058 | 88,058 | 88,058 | |||||||||||
Strategic Subtotal | 2,944,016 | 2,064,140 | 1,284,531 | 811,669 | |||||||||||
Non-Strategic(1) | |||||||||||||||
Other real estate equity | 2,458,871 | 1,186,515 | 1,372,273 | 703,666 | |||||||||||
Net lease real estate equity | 183,171 | 74,804 | 182,174 | 74,447 | |||||||||||
Real estate debt | 416,346 | 416,346 | 290,455 | 290,455 | |||||||||||
CRE securities and real estate PE fund investments | 69,765 | 69,765 | 69,765 | 69,765 | |||||||||||
Non-Strategic Subtotal | 3,128,153 | 1,747,430 | 1,914,667 | 1,138,333 | |||||||||||
Other Equity and Debt Total | $ | 6,072,169 | $ | 3,811,570 | $ | 3,199,198 | $ | 1,950,002 |
(1) | For consolidated real estate equity assets, amounts include all components related to real estate assets, including tangible real estate and lease-related intangibles, and excludes accumulated depreciation, and for all other assets, amounts represent carrying value of investments. |
Colony Capital | Supplemental Financial Report | 36 |
IXa. Other Equity and Debt - Strategic Investments |
($ in thousands, except as noted and per share data; as of March 31, 2019, unless otherwise noted) | Consolidated amount | CLNY OP share of consolidated amount | ||||||
NorthStar Realty Europe Corp. (NYSE: NRE) | ||||||||
CLNY OP interest in NRE as of May 7, 2019 | 11.1 | % | 11.1 | % | ||||
NRE shares beneficially owned by OP and common stockholders | 5.6 million | 5.6 million | ||||||
NRE share price as of May 7, 2019 | $ | 17.30 | $ | 17.30 | ||||
Total market value of NRE shares | $ | 97,511 | $ | 97,511 | ||||
Carrying value - NRE | $ | 88,058 | $ | 88,058 | ||||
CLNY's GP Co-investments in CDCF IV Investments - CLNY's Most Recent Flagship Institutional Credit Fund | ||||||||
Assets - carrying value(1) | $ | 1,770,614 | $ | 317,833 | ||||
Debt - UPB | 508,240 | 101,227 | ||||||
Net carrying value | $ | 1,262,374 | $ | 216,606 | ||||
NBV by Geography: | ||||||||
U.S. | 28.7 | % | 17.3 | % | ||||
Europe | 71.3 | % | 82.7 | % | ||||
Total | 100.0 | % | 100.0 | % | ||||
Other GP Co-investments (2) | ||||||||
Assets - carrying value(3) | $ | 1,085,344 | $ | 878,640 | ||||
Debt - UPB(4) | 371,636 | 371,636 | ||||||
Net carrying value | $ | 713,708 | $ | 507,004 |
(1) | $763 million consolidated or $117 million CLNY OP share of assets are classified as Loans Receivable on the Company's balance sheet. |
(2) | Other GP co-investments represents: i) seed investments in certain registered investment companies sponsored by the Company, ii) investments in the general partnership of third party real estate operators primarily to seed investment commitments with their limited partners for which the Company will receive its share of earnings and incentive fees, or iii) general partnership capital in a fund or investment. |
(3) | $418 million consolidated or $390 million CLNY OP share of assets are classified as Loans Receivable on the Company's balance sheet. |
(4) | Includes $111 million of derivative liability. |
Colony Capital | Supplemental Financial Report | 37 |
IXb. Other Equity and Debt - Net Lease and Other Real Estate Equity |
($ in thousands; as of March 31, 2019, unless otherwise noted) | ||||||||||||||||||||
Net Lease Real Estate Equity | Number of buildings | Rentable square feet (thousands) | Consolidated amount | CLNY OP share of consolidated amount | % leased at end of period | Weighted average remaining lease term | ||||||||||||||
NOI(1) | NOI(1) | |||||||||||||||||||
U.S. office | 3 | 674 | $ | 1,391 | $ | 1,385 | 85.7 | % | 5.6 | |||||||||||
Total / W.A. | 3 | 674 | $ | 1,391 | $ | 1,385 | 85.7 | % | 5.6 |
Other Real Estate Equity | Number of buildings | Rentable square feet (thousands) | Consolidated amount | CLNY OP share of consolidated amount | % leased at end of period | Weighted average remaining lease term | ||||||||||||||
Undepreciated carrying value | Undepreciated carrying value | |||||||||||||||||||
U.S.: | ||||||||||||||||||||
Office | 9 | 785 | $ | 149,797 | $ | 142,370 | 64.5 | % | 5.3 | |||||||||||
Hotel(2) | 89 | N/A | 1,194,861 | 658,658 | 67.9 | % | N/A | |||||||||||||
Europe: | ||||||||||||||||||||
Office | 16 | 545 | 76,490 | 38,245 | 80.2 | % | 12.1 | |||||||||||||
Mixed / Retail | 129 | 4,089 | 630,101 | 204,764 | 57.1 | % | 4.4 | |||||||||||||
Total / W.A. | 243 | 5,419 | $ | 2,051,249 | $ | 1,044,037 | 60.5 | % | 5.3 | |||||||||||
Unconsolidated joint ventures (Other RE Equity) | ||||||||||||||||||||
Preferred equity: | ||||||||||||||||||||
Multifamily | $ | 202,801 | $ | 202,801 | ||||||||||||||||
Equity & Other: | ||||||||||||||||||||
Albertsons | 89,129 | 44,565 | ||||||||||||||||||
Residential Land | 70,965 | 36,142 | ||||||||||||||||||
Other | 28,742 | 28,742 | ||||||||||||||||||
Corporate CLO Equity | 15,986 | 15,986 | ||||||||||||||||||
Total | $ | 407,623 | $ | 328,236 | ||||||||||||||||
(1) | Excludes a $1.9 million consolidated and CLNY OP share tenant termination fee received and NOI related to an asset sold during the first quarter 2019. |
(2) | Includes $77 million consolidated or $42 million CLNY OP share of restricted cash. |
Colony Capital | Supplemental Financial Report | 38 |
IXc. Other Equity and Debt - Real Estate Debt |
($ in thousands, except as noted; as of March 31, 2019, unless otherwise noted) | ||||||||
Portfolio Overview(1) | ||||||||
Consolidated amount | CLNY OP share of consolidated amount | |||||||
Non-PCI loans(2) | ||||||||
Carrying value - consolidated | $ | 328,608 | $ | 236,107 | ||||
Carrying value - equity method investments | 22,053 | 14,533 | ||||||
. | ||||||||
PCI loans(2) | ||||||||
Carrying value - consolidated | 26,058 | 15,455 | ||||||
Carrying value - equity method investments | 1,004 | 1,004 | ||||||
Other | ||||||||
Carrying value - real estate assets (REO) | 38,624 | 23,355 | ||||||
Total Portfolio | ||||||||
Carrying value - consolidated | 354,666 | 251,562 | ||||||
Carrying value - equity method investments | 23,057 | 15,537 | ||||||
Carrying value - real estate assets (REO) | 38,624 | 23,355 | ||||||
Non-recourse investment-level financing (UPB) | — | — |
(1) | Excludes $50 million consolidated or $35 million CLNY OP share carrying value of healthcare real estate development loans. |
(2) | Strategic Non-PCI and PCI loans that are classified as Loans Receivable on the Company's balance sheet are categorized within GP co-investments in this supplemental financial presentation. |
Colony Capital | Supplemental Financial Report | 39 |
IXc. Other Equity and Debt - Real Estate Debt (cont’d) |
($ in thousands; as of or for the three months ended March 31, 2019, unless otherwise noted) | ||||||||||||||
Non-strategic real estate debt by loan type(1) | ||||||||||||||
Consolidated amount | CLNY OP share of consolidated amount | |||||||||||||
Net carrying amount | Net carrying amount | Weighted average yield | Weighted average maturity in years | |||||||||||
Non-PCI loans(2) | ||||||||||||||
Fixed rate | ||||||||||||||
First mortgage loans | $ | 36,488 | $ | 18,244 | — | % | 1.2 | |||||||
Second mortgage loans / B-notes | 173,495 | 97,548 | 9.2 | % | 2.0 | |||||||||
Mezzanine loans | 63,387 | 60,672 | — | % | 1.6 | |||||||||
Corporate | 27,778 | 27,778 | 8.2 | % | 7.8 | |||||||||
Total fixed rate non-PCI loans | 301,148 | 204,242 | 5.5 | % | 2.6 | |||||||||
Variable rate | ||||||||||||||
First mortgage loans | 45,575 | 45,575 | 8.7 | % | 1.7 | |||||||||
Total variable rate non-PCI loans | 45,575 | 45,575 | 8.7 | % | 1.7 | |||||||||
Total non-PCI loans | 346,723 | 249,817 | ||||||||||||
Allowance for loan losses | (18,115 | ) | (13,710 | ) | ||||||||||
Total non-PCI loans, net of allowance for loan losses | 328,608 | 236,107 | ||||||||||||
PCI loans(2) | ||||||||||||||
First mortgage loans | 40,390 | 20,936 | ||||||||||||
Mezzanine loans | 3,671 | 3,671 | ||||||||||||
Total PCI loans | 44,061 | 24,607 | ||||||||||||
Allowance for loan losses | (18,003 | ) | (9,152 | ) | ||||||||||
Total PCI loans, net of allowance for loan losses | 26,058 | 15,455 | ||||||||||||
Total loans receivable, net of allowance for loan losses | $ | 354,666 | $ | 251,562 |
(1) | Excludes $50 million consolidated or $35 million CLNY OP share carrying value of healthcare real estate development loans. |
(2) | Strategic Non-PCI and PCI loans that are classified as Loans Receivable on the Company's balance sheet are categorized within GP co-investments in this supplemental financial presentation. |
Colony Capital | Supplemental Financial Report | 40 |
IXc. Other Equity and Debt - Real Estate Debt (cont’d) |
($ in thousands; as of or for the three months ended March 31, 2019, unless otherwise noted) | ||||||||||||||
Non-strategic real estate debt by collateral type(1) | ||||||||||||||
Consolidated amount | CLNY OP share of consolidated amount | |||||||||||||
Net carrying amount | Net carrying amount | Weighted average yield | Weighted average maturity in years | |||||||||||
Non-PCI Loans(2) | ||||||||||||||
Retail | $ | 130,462 | $ | 123,145 | 3.2 | % | 1.4 | |||||||
Office | 135,729 | 67,865 | 13.2 | % | 2.8 | |||||||||
Land | 34,639 | 17,319 | — | % | 1.2 | |||||||||
Corporate | 27,778 | 27,778 | 8.2 | % | 7.8 | |||||||||
Total non-PCI loans, net of allowance for loan losses | 328,608 | 236,107 | 6.4 | % | 2.5 | |||||||||
PCI Loans(2) | ||||||||||||||
Retail | 16,000 | 8,237 | ||||||||||||
Office | 4,629 | 3,825 | ||||||||||||
Other | 5,429 | 3,393 | ||||||||||||
Total PCI loans, net of allowance for loan losses | 26,058 | 15,455 | ||||||||||||
Total loans receivable, net of allowance for loan losses | $ | 354,666 | $ | 251,562 |
(1) | Excludes $50 million consolidated or $35 million CLNY OP share carrying value of healthcare real estate development loans. |
(2) | Strategic Non-PCI and PCI loans that are classified as Loans Receivable on the Company's balance sheet are categorized within GP co-investments in this supplemental financial presentation. |
Colony Capital | Supplemental Financial Report | 41 |
IXd. Other Equity and Debt - CRE Securities and Real Estate PE Fund Interests |
($ in thousands; as of March 31, 2019) | |||||
Portfolio Overview | Carrying Value | ||||
Deconsolidated CDO bonds | $ | 64,212 | |||
CMBS | 198 | ||||
Real estate PE fund interests | 5,355 | ||||
Core FFO | |||||
Q1 2019 aggregate Core FFO(1) | $ | 3,032 |
(1) | Excludes $2.0 million consolidated and CLNY OP share of impairments. |
Colony Capital | Supplemental Financial Report | 42 |
Xa. Investment Management - Summary Metrics |
($ in thousands, except as noted; as of March 31, 2019) | Q1 2019 Fee Revenue - CLNY OP Share | |||
Overview | ||||
Institutional funds | $ | 13,110 | ||
Colony Credit Real Estate (NYSE:CLNC) | 11,219 | |||
NorthStar Realty Europe (NYSE:NRE) | 3,887 | |||
Retail companies | 5,284 | |||
Non-wholly owned REIM platforms (equity method earnings)(1) | 8,053 | |||
Total reported fee revenue and REIM platform equity method earnings | $ | 41,553 | ||
Operating Results | ||||
Revenues | ||||
Total fee revenue and REIM earnings of investments in unconsolidated ventures | $ | 41,553 | ||
Interest and Other income | 8,977 | |||
Expenses | ||||
Investment and servicing expense | 3,956 | |||
Transaction costs | 1,731 | |||
Placement fees | 309 | |||
Depreciation and amortization | 8,669 | |||
Compensation expense | ||||
Cash and equity-based compensation | 11,550 | |||
Carried interest and incentive compensation | 1,051 | |||
Administrative expenses | 865 | |||
Total expenses | 28,131 | |||
Other gain (loss), net | 55 | |||
Equity method earnings | (3,793 | ) | ||
Equity method earnings—carried interest | 3,205 | |||
Income tax benefit (expense) | 12 | |||
Net income attributable to common interests in OP and common stockholders | 21,878 | |||
Real estate depreciation and amortization | 1,889 | |||
(Gains) and losses from sales of businesses and impairment write-downs associated with the Investment Management segment | 2,542 | |||
Equity-based compensation expense | 1,944 | |||
Straight-line rent revenue and expense | 45 | |||
Amortization of deferred financing costs and debt premiums and discounts | 76 | |||
Acquisition and merger-related transaction costs | 1,731 | |||
Amortization and impairment of investment management intangibles | 8,662 | |||
Non-real estate depreciation and amortization | 7 | |||
Deferred tax (benefit) expense, net | (2,483 | ) | ||
Core FFO | $ | 36,291 |
(1) | Includes $3 million of unrealized carried interest from a REIM platform. |
Colony Capital | Supplemental Financial Report | 43 |
Xb. Investment Management – Assets Under Management |
($ in millions, except as noted; as of March 31, 2019, unless otherwise noted) | |||||||||||||||
Segment | Products (FEEUM) | Description | AUM CLNY OP Share | FEEUM CLNY OP Share | Fee Rate | ||||||||||
Institutional Funds | • Credit ($2.6 billion) • Core plus / value-added ($0.2 billion) • Opportunistic ($0.5 billion) • Colony Industrial ($1.9 billion) • Other co-investment vehicles ($1.3 billion) | • 27 years of institutional investment management experience • Sponsorship of private equity funds and vehicles earning asset management fees and performance fees • More than 300 investor relationships • Colony Industrial Open-End Fund | $ | 9,893 | $ | 6,580 | .8 | % | |||||||
Public Companies | • Colony Credit Real Estate, Inc. ($3.0 billion) • NorthStar Realty Europe Corp. ($1.0 billion) | • CLNC: NYSE-listed credit focused REIT • NRE: NYSE-listed European equity REIT • Contracts with base management fees with potential for incentive fees | 5,126 | 4,068 | 1.5 | % | |||||||||
Retail Companies | • NorthStar Healthcare ($1.3 billion)(1) • CC Real Estate Income Funds(2)(3) | • Manage public non-traded vehicles earning asset management and performance fees | 3,470 | 1,365 | (1) | 1.5 | % | ||||||||
Non-Wholly Owned REIM Platforms | • Digital Real Estate Infrastructure Co-sponsored Vehicle • RXR Realty • American Healthcare Investors • Steelwave • Hamburg Trust | • CLNY recognizes at-share earnings from underlying non-wholly owned REIM platforms • 50% investment in Digital Colony, the Company's digital real estate infrastructure vehicle established in partnership with Digital Bridge with an aggregate $4 billion of committed capital • 27% investment in RXR Realty, a real estate owner, developer and investment management company with $18 billion of AUM • 43% investment in American Healthcare Investors, a healthcare investment management firm and sponsor of non-traded vehicles with $3 billion of AUM | 10,336 | 5,738 | N/A | ||||||||||
Total | $ | 28,825 | $ | 17,751 |
(1) | FEEUM of NorthStar Healthcare Income represents its most recently published Net Asset Value. |
(2) | CC Real Estate Income Funds represents a master/feeder structure and pools investor capital raised through three feeder funds. |
(3) | In February 2019, the board of directors of CC Real Estate Income Fund approved a plan to dissolve, liquidate and terminate CCREIF and distribute the net proceeds of such liquidation to its shareholders. There is no assurances to the timing or completion of the liquidation. |
Colony Capital | Supplemental Financial Report | 44 |
Colony Capital | Supplemental Financial Report | 45 |
XIa. Appendices - Definitions |
Colony Capital | Supplemental Financial Report | 46 |
XIa. Appendices - Definitions |
Colony Capital | Supplemental Financial Report | 47 |
XIb. Appendices - Reconciliation of Net Income (Loss) to NOI |
($ in thousands; for the three months ended March 31, 2019) | ||||||||||||||||
NOI Determined as Follows | Healthcare | Industrial | Hospitality | Other Equity and Debt—Net Lease Properties | ||||||||||||
Total revenues | $ | 145,774 | $ | 82,372 | $ | 196,615 | $ | 3,072 | ||||||||
Straight-line rent revenue and amortization of above- and below-market lease intangibles | (5,227 | ) | (3,232 | ) | 310 | (361 | ) | |||||||||
Interest income | — | (180 | ) | — | — | |||||||||||
Property operating expenses(1) | (64,302 | ) | (22,337 | ) | (136,345 | ) | (1,320 | ) | ||||||||
Compensation and administrative expense(1) | — | (784 | ) | — | — | |||||||||||
NOI(2) | $ | 76,245 | $ | 55,839 | $ | 60,580 | $ | 1,391 | ||||||||
Reconciliation of Net Income (Loss) from Continuing Operations to NOI | ||||||||||||||||
Healthcare | Industrial | Hospitality | ||||||||||||||
Income (loss) from continuing operations | $ | (7,206 | ) | $ | 24,154 | $ | (26,077 | ) | ||||||||
Adjustments: | ||||||||||||||||
Straight-line rent revenue and amortization of above- and below-market lease intangibles | (5,227 | ) | (3,232 | ) | 310 | |||||||||||
Interest income | — | (180 | ) | — | ||||||||||||
Interest expense | 47,527 | 14,627 | 42,065 | |||||||||||||
Transaction, investment and servicing costs | 3,108 | 530 | 1,584 | |||||||||||||
Depreciation and amortization | 40,131 | 39,445 | 36,248 | |||||||||||||
Impairment loss | — | — | 3,850 | |||||||||||||
Compensation and administrative expense | 1,653 | 3,504 | 1,904 | |||||||||||||
Gain on sale of real estate | — | (22,848 | ) | (139 | ) | |||||||||||
Other (gain) loss, net | (1,867 | ) | 8 | (1 | ) | |||||||||||
Income tax (benefit) expense | (1,874 | ) | (169 | ) | 836 | |||||||||||
NOI(2) | $ | 76,245 | $ | 55,839 | $ | 60,580 |
(1) | For healthcare and hospitality, property operating expenses includes property management fees paid to third parties. For industrial, there are direct costs of managing the portfolio which are included in compensation expense. |
(2) | For hospitality, NOI is before FF&E Reserve. |
Colony Capital | Supplemental Financial Report | 48 |
XIb. Appendices - Reconciliation of Net Income (Loss) to NOI (cont’d) |
($ in thousands; for the three months ended March 31, 2019) | ||||
Reconciliation of Net Income from Continuing Operations of Other Equity and Debt Segment to NOI of Net Lease Real Estate Equity | ||||
Other Equity and Debt | ||||
Income from continuing operations | $ | 59,563 | ||
Adjustments: | ||||
Property operating income of other real estate equity | (112,507 | ) | ||
Straight-line rent revenue and amortization of above- and below-market lease intangibles for net lease real estate equity | (378 | ) | ||
Interest income | (43,662 | ) | ||
Fee and other income | (1,373 | ) | ||
Property operating expense of other real estate equity | 68,593 | |||
Interest expense | 31,853 | |||
Transaction, investment and servicing costs | 7,269 | |||
Depreciation and amortization | 24,783 | |||
Provision for loan loss | 3,611 | |||
Impairment loss | 21,772 | |||
Compensation and administrative expense | 3,637 | |||
Gain on sale of real estate assets | (29,314 | ) | ||
Other loss, net | (8,047 | ) | ||
Earnings of investments in unconsolidated ventures | (24,608 | ) | ||
Income tax expense | 2,074 | |||
NOI of net lease real estate equity | $ | 3,266 | ||
Less: tenant termination fee and NOI of an asset sold in Q1 2019 | (1,875 | ) | ||
NOI of net lease real estate equity, excluding tenant termination fee and NOI of asset sold | $ | 1,391 |
Colony Capital | Supplemental Financial Report | 49 |